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Abstract
It has become clear that protein tyrosine phosphorylation 
plays a central role in cellular regulat ion and uiral 
transformation. Rdenoufrus DNR-binding protein (DBP) is a 
m ult i- funct ional  phosphoprotein and a preuious study  
suggested that OBP is phosphorylated at a tyrosine residue 
(Russell et al, 1989). In order to inuestlgate tyrosine  
phosphorylation of OBP, attempts mere made to prepare  
polyclonal and monoclonal antibodies against phosphotyrosine 
(Ptyr) and DBP (adenouirus typeZ ONR-bindIng protein) mith 
success except In the case of the monoclonal antibody (MRb) 
against Ptyr (Part I). These antibodies mere used in parallel 
to detect any Ptyr of OBP in an immunoassay (Part I I) .  Rntl- 
OBP polyclonal antibody mas used in Immunoprécipitation as 
mell as mestern blotting and MRb to OBP mas used in mestern 
blotting and immunofluorescence. Rnti-OBP MRb mas also 
used in characterizing the DNR-bindIng domain of OBP. 
Poiycionai an t i  P ty r  an t ibody  re a c te d  mell  mith  
p h o s p h o t y r o s i n e - c o n t a l n i n g  p r o t e i n  E6 FR In 
immunofluorescence, immunoprécipitation and mestern  
blotting but failed to detect Ptyr In OBP in these assays, 
mhereas a synthetic peptide DBPPT195, mhich consists of a 
putatiue tyrosine phosphorylation site of OBP [aa (amino acid) 
195] and Its surrounding residues (aa188-aaZ01 ), mas shomn 
to be phosphorylated in uitro. In order to obtain an 
unphosphorylated OBP and mutate the tyrosine (mhich mas 
suggested to be phosphorylated) of OBP, an at tem pt to 
express OBP in E.coll mas also made (Part I I I ) .  The OBP gene
mas Inserted Into pGEH-2T uector but the production of fusion 
protein In E.coll mas uery p o o r .
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Introduction
Three topics are reuieured here: 1. adenouiruses that encode the 
DBP protein; 2. protein phosphorylation that modulates the DBP 
protein; 3. the DBP protein that has been utilised mith in this mork.
1. Rdenouirus
The adenouiruses are a group of DNR uiruses that infect 
uertebrate  cells and in humans cause mainly respiratory  
disease. These uiruses lack enuelopes and contain only DNR 
and proteins. They replicate and assemble their progeny in the 
nuclei of the infected cells, the uiral polypeptides being 
synthesized in the cytoplasm and all transported to the 
nuclei. The uirons are released uia cell destruction ( Ginsberg, 
1984 ).
There are 47 serotypes of the adenouiruses mhich haue 
been identified to date in humans. They share many common 
features including uirion architecture, genome organisation, 
polypeptide composition and repiicatiue cycles etc. On the 
basis of oncogenicity and other biological & structural  
properties, the 47 different serotypes human adenouirus are 
subdiuided Into six groups of R-F ( LUadell, 1987 ). The most 
commonly used adenouiruses in laboratory studies mith 
cultured cells are the human types 2 and 5. They belong to 
non-oncogenic group C.
1.1. Rrchitecture of  an adenouirion
Electron micrographs shorn that the adenouiruses ail 
haue a uery characteristic icosahedral structure about 80nm 
in diameter (Tooze, 1973). The uirion of an adenouirus consists
of an outer capsid ( a protein shell ) and a dense central core 
( uiral genome associated mith uirion polypeptides ).
Caosid The capsid of an adenouirion comprises 252  
capsomers that are arranged into an icosahedron about 8Qnm 
in diameter. Among these, the 240 capsomers that occupy the 
facets and edges of the icosahedron are called hexons C they 
haue six neighbors ), and the remaining 12 are pentons ( they 
haue fiue neighbors instead ). The penton Is made up mith a 
penton base that sits at the uertice of the icosahedron and a 
f iber that projects from the base. The hexons are either  
"peripentonar or in the "group of nine distinguished by their 
location in the capsid ( Fig. 1. B. ). Peripentonal hexons are 
the hexons that surround the pentons, and all the rest of the 
hexons are included in the groups of nine hexons since these 
nine hexons are released as a mhole a f te r  uirion disruption 
( Tooze, 1973 ).
Core The major components of à core of an adenouirion 
comprise one l inear double-stranded DNB molecule of  
approximate 35 kilobase pairs long, tmo proteins that closely 
associate mith the DNR to form a DNR-protein complex, and 
tmo copies of a 55K terminal protein coualentiy linked to the 
5' ends of the DNR ( Russell et al, 1971; Rekosh et al, 1977 ). 
The DNR-protein complex is formed in such a manner that the 
DNR molecule can be compacted ouer 5-fold In length in the 
core ( Mirza and LUeber, 1982 ).
Uirion oolyoeotides SDS polyacrylamide gel electrophoresis 
analysis shom that there are at least eleuen polypeptides in 
an adenouirion { Fig. 1. B. ). Polypeptides II ( 120K ), I I I  ( 85K ) 
and ID ( 62K ) present three major capsid proteins of hexon.
penton base and fiber respectiuefy: The henon is a tr imer of 
three identical polypeptides II held tiyhtly toyether by non- 
coualent interactions, the penton base is a pentamer of
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Fig. 1. Schematic representation of an adenouirion
A. The location of uarious components in the 
adenouirion capsid (from Tooz, 1973 pp.424)
B. The polypeptides of the adenouirion resolued 
by SOS-polyacrylamide yel electrophoresis 
(from Hormitz, 1986 pp.565)
polypeptide i l l  and the fiber is a trimer of polypeptide lU. The 
trimer of polypeptide !U non-coualentiy attaches to the 
pentamer of polypeptide I I I  to form the penton. The henons, 
penton bases and fibers of the capsid are the proteins that  
carry uarious antiyenic determinants of the adenouiruses. 
Thus they are uery important in uiral classification and clinical 
diaynosis. Minor components of capsid proteins are  
polypeptides Ul ( 24K ), Ull l  ( 13K ), IB ( 12K ) and I l ia  ( 66K ), 
of Luhich, Ul, Ull l  and \W are found to be associated mith the 
henons, and 11 la appears to be in contact mith both penton 
base and peripentonal hexon. It may also extend through the 
capsid and haue contact mith core proteins, thus I l i a  may 
serue a bridging function betmeen the core and the capsid C 
Hormitz, 1986 ). Polypeptides U ( 4 8 .5K ) and Ul I ( 18.5K ) are 
tmo major proteins in the core. They are both rich in arginine 
and other basic amino acids, and they are both non-coualently 
linked to the UNA to form the complex. But polypeptide Ul I 
binds to DNA more tightly than polypeptide U. The complex 
betmeen polypeptide Ul I and DNA is uery stable. On mild 
dissociation mith pyridine or sodium deoxycholate, the la t ter  
can be easily remoued from the complex mhile the former can 
not. The amount of polypeptide Ul I in the core is also more 
abundant than polypeptide U ( about 6-fold ).
1.2. Genome organisation
The adenouirus genome is a linear double-stranded DNA 
molecule of approximate 35 kilobase pairs (Kbp) in length. 
Each strand has a short sequence of about IQObp long at one 
end that Is complementary to the sequence at the other end.
Le. an inverted terminai repeat (ITR) structure, and a 55K 
terminai protein (TP) couaientiy linked to the 5' end. The mhole 
genome is conuentionaliy divided into 0-100 map units ( m.u ) 
from the extreme left-hand end to the extreme right (Fig.2; 
Hormitz, 1986). There are four early and fiue late regions or 
transcription units that haue been mapped in the genome.
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Fig. 2. The adenouirus genome and its RNfl transcripts. 
The proteins encoded by each RNR group are listed 
either above or belom this group. The roman 
numerals indicate uirion polypeptides and 
nonstructural proteins are indicated in kllodaltons, 
some by function as mell (from Hormitz, M. S. 1986 
pp.588).
From left  to right, the right (r) strand mhich is transcribed 
rightmards contains early region 1 ( El; m.u 1.3-11.2 ), late 
regions 1 to 5 ( L1-L5; m.u 16.45-99), and early region 3 (E3; 
m.u 76 .6 -86 .2 ) .  From right to le f t ,  the le f t  (I) strand,  
transcribed to the left, contains early regions 4 (E4; m.u 96.8-  
91.3) and 2 (E2, m.u 75.2-14.2).  The "early" (E) designates 
those regions of the genome mhich are expressed before the 
onset of uirai DNR replication. Dnce uiral DNR synthesis is 
initiated, the gene expression turns to' late" (L),
Early regions 1 and 2 ( El D E2 ) El Is subdiuided into E1R 
( m.u 1.3-4.5) and ElB (m.u 4.6-11.2). Because it specifies tmo 
separate transcription units by mapping of promoter sites and 
mRNRs mithin this site, there are several regulatory elements 
of EIR. Three major mRNRs of 13S, 12S and 9S are generated 
from this promoter by different splicing. Df these, 13S mRNR 
codes for a 289 amino acid residues long (289R) protein that is 
required for the activation of all other early gene expression 
and 12S mRNR codes for a 243R protein. The ElB promoter site 
Is located at m.u 4.7. Similarly it generates tmo major mRNRs 
of 22S and 13S, coding for a 55K and 19K polypeptides. Both 
EIR and ElB proteins are tumour antigens (reuiemed by 
Boulanger and Blair, 1991). The E2 region is also subdiuided 
into E2R (m.u 67.9-61.5) and E2B (m.u 29-14.2). They share the 
same promoter mhich is located at m.u 75 during early times 
of infection and shifted to m.u 72 at late times as uiral DNR 
synthesis has been in i t ia ted .  E2R codes fo r  a 72K 
multifunctional DNR-binding protein (DBP) and E2B codes for a 
87K preterminal protein (pTP) and a 140K DNR polymerase
(pol). DBP, pTP and pot are three uiral replication proteins 
( Hkusjarul et al, 1986 ).
Late regions 1 to 5 (11 -15) Late transcription units are 
characterized by polyadenylation sites of their transcripts. 
There are fiue possible locations of polyadenylation sites that 
lie doLunstream along the genome, generating fiue families of 
LI to L5 (Fig. 2). The mRNHs in each family haue common 5' and 
3' termini, and d if fe r  by d if ferent length of intron being 
remoued during splicing. All late mRNRs are generated from a 
single promoter— the major late promoter (MLP) at m.u 16.45. 
They encode mainly uiral structural proteins as indicated in 
Fig. 2.
1.3. Mult ip l ica t ion  cycle
Comparing mith other uiruses, adenouiruses haue a 
prolonged period of about 12-18 hours for multiplication. This 
differs mith multiplicity of infection, cell-uirus system and 
physiological conditions.
A ttachm ent,  p en e tra t ion  and uncoating I t  has been 
suggested (Philipson et al, 1968) that an adenouirion attaches 
to a cell by binding to its specific receptors on the membrane 
of the cell. There are approximately 10  ^ uirion receptors and 
105 f iber  receptors of adenouiruses in each host cell 
membrane. This implies that the binding mechanism is 
muitiualent. An early study (Morgan et al, 1969) shomed that 
the particles of adenouiruses enter  the celi by passing 
directly through the plasma membrane, i.e. translocation. But 
there is increasing evidence shoming that the entry could also 
be receptor-mediated endocytosis (Chardonnet and Dales,
1970; Suensson, 1985). fis adenouiruses enter  the cell, It 
e i th e r  loses some pentons and peripentonal  hexons 
(Sussenbach, 1967), resulting in partial uncoating of the 
uirion; or ieads to a conformational change of the capsid in 
the endosome vesicles, resulting in loss of capsid proteins, 
e.g. a conformation change in hexon induced by lorn pH results 
in the exposure of endoproteolytic sites of the protein  
(Eueritt et al, 1988). Once the capsid is remoued, the core 
migrates to the cell nucleus. There uiral DNH Is released and 
transcription takes place.
T ranscr ip t ion  The adenouirus genome is transcribed in 
sequences (i.e. transcription units) by its host cell DNfi- 
dependent RNfl polymerase I I .  There are tuio stages of 
transcription — early and late in an adenouirus infection. Uiral 
regulatory and replication proteins are made from mRNRs 
transcribed at the eariy stage and uirion proteins are made at 
the late stage. Early transcription starts from the EIR region 
immediately a f te r  infection. EIR 289R protein possesses a 
transactiuation actiuity and stimulates the transcription  
directed by RNR polymerase I! from many promoters including 
ElB, E2, E3, E4 and EIR itself. This is accomplished by altering 
the actiuity of uarious transcription factors that recognize 
the specific regulatory  sequences upstream from the  
promoters (Flint and Shenk, 1989). Thus transcription of the 
EIR region is follomed by transcription of regions ElB, E3, E4, 
and last of all, region E2, In addition to EIR 289R protein, E2 
early transcription also requires an E4 gene product, a 17K 
polypeptide (Babiss, 1989; Reichel et al, 1989). The E2 region is 
of some special interest. It is the oniy transcription unit in an
adenouirus that appears to use alternative promoter sites for 
its transcription. Rt early times, the early promoter of E2 Is 
activated by a cellular DNR-binding fac tor  E2F luhiie the 
activation of E2F requires EIR 289R and E4 17K proteins. In 
contrast, the E2 late promoter, mhich is active only at late 
phase of infection, is refractory to the transactiuation of EIR 
289R protein (Berk, 1986). Its actluition undergoes a different  
mechanism mhich is currently unclear. Both early and late 
promoters of E2 generate tmo groups of spliced primary  
transcripts E2R mRNR and E2B mRNR. The amount of the tmo 
mRNRs differs greatly one from the other. E2B mRNR is about 
100-fo id  lesser than E2R mRNR (Stillman et al, 1981). 
RIternatiue and independent function of tmo promoters  
alloms transcr ip t ion  of E2 region to be regu la ted  
Independently at early and late t imes. Once uiral DNR 
replication begins, fate gene transcription becomes dominant. 
The late mRNRs and the proteins they encode are produced in 
large quantities at late times (Flint, 1982).
DNR replication There are tmo character is t ics in the  
adenouirus DNR replication: it almays begins directly at either  
end of the DNR, continuously but asynchronously, in a 5' to 3' 
direction; it does not require RNR primers, instead it employs 
a protein-priming mechanism in mhich a precursor of the uiral 
terminal protein (pTP) is coualentiy bound to a dCMP residue 
of the uiral terminal nucleotide, I.e. the 3 -OH group in the 
pTP-dCMP complex is used as a primer. This form of DNR 
synthesis Involves a displacement process. LUhen DNR 
synthesis starts, only one strand serves as a template. Rs the 
synthesis proceeds, the non-template  strand is gradually
released from the parental DNH molecule and finally displaced 
by the neuily synthesized DNH. The displaced single strand can 
then form a panhandle structure resulting from base pairing 
of its inuerted terminai repeats (ITRs) and serue as a 
template for a second round of DNA synthesis (reuiemed by 
Hay and Russell, 1989; Challberg and Kelly, 1989; Stillman,
1989).
Extensive mutational analysis has defined that the origin 
of adenouirus DNR replication Is located mithin the terminal 
51bp of the genome at e ither end. It  comprises a highly 
conserued core domain (terminal 1-18 bp) mhich alone is able 
to support initiation of DNR replication both in uiuo and in 
uitro but only to a limited extent (Challberg and Hamlins, 
1984; Hay, 1985; LUides et al, 1987), and an auxiliary region 
(terminal 19-51 bp) mhich can enhance the initiation reaction 
up to 100-fold (Ramlins et al, 1984; Rosenfeld et al, 1987). it 
is nom clear that the auxiliary region of the origin contains 
tmo cis-acting sequences that are recognized by NF I (cell 
nuclear factor I) and NF I I I  (cell nuclear factor I I I ) ,  the tmo 
cellular sequence-specific DNR-binding proteins that are 
required for  e ff ic ient uiral DNR replication. One of the 
mechanisms involved in eukaryote’s control of transcription 
and replication results from the interplay betmeen regulatory 
DNR sequences and their multiple site-specific DNR- binding 
proteins (Johnson and Mcknight, 1989). In eukaryatic DNR 
uiruses, the origins of replication frequ en t ly  contain  
transcription regulatory sequences that function as auxiliary 
regions enhancing the init iation of DNR replication (de 
Pamphllis, 1988). The enhancement is achieved by binding of
10
this region to its specific protein such as NF! and NF 111. NFI 
and NF 111 are identical to CCflflT-binding transcription factor  
CTF and octamer-binding transcription factor OTF-I or Oct-I 
respectively (Jones et al, 1987; O'Neill et al, 1988). The 
recognition sequence for NFI is next to the core origin but 
separated from the core by a precisely defined spacer region, 
Uihere sequence changes are tolerated ivhile insertions and 
deletions are not ( fldhya et al, 1986; Coenjaerts et ai, 1991). 
NFI binds to DNR as a dimer symmetrically at one side of the 
helix, making contacts ivith the major groove of DNR (de Dries 
et al, 1987; Gounari et al, 1990). The recognition sequence for  
NF I I I  is immediatly adjacent to the NFI's and actually overlap 
for  tivo nucleotides. Insertion of tmo or more base pairs 
betmeen the tmo sequences almost completely abolishes the 
stimulation of initiation raised by NF i l l  (Pruijn et al, 1988; 
Coenjaerts et al, 1991), suggesting that the position of NF I I I  
binding site is essential for its enhancement. NF I I I  binds to 
DNR at both sides of the helix, making contacts mith both the 
m ajor and minor grooves of DNR. Although the tmo proteins 
are in close proximity, no contacts betmeen them haue been 
demonstrated so far. They function independently, employing 
different mechanisms (Mul et al, 1990). NFI Is fully capable of 
stimulating DNR replication in the absence of NF I I I  and vice 
versa. Homeuer the level of stimulation by NFI is dependent 
on the concentration of pTP-pol complex, the tmo closely 
related uiral proteins that are attributed to the centre of DNR 
replication, and there is an evidence shoming that NFI directly 
interacts mith poi (Bosheret al, 1990).
11
Initiation of adenouirus type 4 (Rd4) DNR replication is an 
exception to the aboue description. The inuerted terminal  
repeat of Rd4 does not contain the NFI recognition site. 
RIthough it does haue a binding site for NF I I I ,  neither factor  
Is required for DNR replication in uiuo or is capable of 
stimulating DNR replication in uitro (Hay et al, 1988). It  has 
been demonstrated (Hay, 1985; Harris and Hay, 1988) that an 
efficient DNR replication of Rd4 requires only the terminal 
18bp of the genome, i.e. the core origin, and the three uiral 
proteins: pTP (preterminal protein), pol (DNR polymerase) and 
DBP (DNR-binding protein). This implies that the terminal 18 bp 
of the genome constitutes a fully functional origin of DNR 
replication and it can be recognized by uiral proteins in the 
absence of cellular proteins. Gel electrophoresis DNR-binding 
and DNase I footprint analysis haue demonstrated that the 
heterodimer of pTP-pol complex specifically recognizes the 
sequence of uiral origin mithin terminal 1-18 bp and protects 
its 8 -17  bp from nuclease cleavage (Temperley and Hay, 
1992).
The initiation takes place mhen a covalent bond betmeen 
the a-phosphoryl group of either terminal dCMP residue in 
DNR and the p-OH group of a serine residue in pTP is formed. 
Fiue proteins are involved in this reaction as mentioned 
aboue. Homeuer pTP and pol alone either cannot bind to the 
DNR origin (Chen et al, 1990) or haue reiatiueiy lom specificity 
and affinity for the origin (Temperley and Hay, 1992). They 
must function as a complex. The complex of pTP-pol binds to 
DNR preferably to single-stranded (Kenny and Hurmitz, 1988; 
Chen et al, 1990), suggesting that an unmound region of origin
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must be presented prior to the binding. NFI and NF ISI can 
bind to their recognition sites independently, and the binding 
of NFI to DNfl is enhanced by DBF (Stuiuer and uan der Uliet,
1990). DBF Is also able to stimulate initiation in the absence of 
NFI Luith a currently unknomn mechanism. NFI Interacts uiith 
pol as Luell and in doing so directs pTF pol to the origin, and at 
the same time stabilizes the complex betmeen pTF-pol and 
core origin (Mul and uan der Uliet, 1992). Thus it can be 
concluded from these results that protein protein and 
proteln-DNfl interactions at the origin are indeed required 
prior to initiation, leading to the formation of an eff icient  
preinitiation complex containing all the flue proteins and the 
origin or only the three uiral proteins and the origin, and the 
generation of a functional partially single-stranded DNR 
template.
Once the initiation has taken place, further DNR synthesis 
falls into the strand displacement mechanism cooperated by 
pol and DBF. Complete chain elongation of nascent DNR 
molecule requires an additional cellular protein NF II (cell 
nuclear factor I I )  luhich has a topoisomerase I actiuity to 
remoue torsional strain induced by the displacement process 
(Nagata et al, 1983).
Assembly and release Uirion assembly is confined to the 
nucleus, and it begins mhen single polypeptides are  
assembled Into capsomers (Russell et al, 1967; Horujitz et al, 
1969). The formation of hexon capsomers from monomers 
(polypeptide I I )  to a trimer is mediated by a uirus-coded 100K 
protein (Cepko and Sharp, 1983). It is a nonstructural late 
protein and present in large quantities in infected cell
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ex t racts  but absent from mature uirions. UJhen hexon 
capsomers are formed, they then self-assemble into a empty 
procapsid, presumably through the formation of ninemers 
ujith polypeptide that mould occupy each of the 20 faces of 
the uirion. Proteins that associate uiith hexon ninemers at 
this stage are precursors of polypeptides Ul (pUI) and Ullt  
(pUMI). The formation of penton capsomers from flue penton 
base and three fiber polypeptides ( I I I  and lU respectiuely) is 
not clear. Folloming procapsid formation, the DNR and core 
proteins are inserted. It appears that the insertion of DNR is 
progressed in the absence of core proteins, thus another  
basic protein mould be needed to neutralize the charge of the 
DNR before its packaging. This basic protein possibly is the 
uirus-coded DBF (Nicolas et al, 1983). Because the left first 
400 bp of the gemome contains a specific recognition  
sequence for DNR packaging (Hammarskjold and LDinberg, 
1980),  the DNR enters the preform ed capsid almays  
preferentially from the left-hand end. Folloming insertion of 
DNR and core proteins, the proteolytic process of precursors 
(e.g. pUI, pUII, pUIII  and pTF) is carried out by a uirus-coded 
23K protease (LUebster et al, 1989). The uirion particle then 
tightens its configuration and becomes mature. Uirions 
assembly can be blocked by arginine depriuation (Russell and 
Becker, 1968). Rssembled uirions are accumulated in the 
nucleus, mhere they form crystalline aggregates mhich can be 
seen by electron microscopy. They are released from the 
nucleus only mhen the nuclear membrane is disrupted, and 
then escape from the host cell by cell lysis.
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2, Pro tein phosphorylat ion
Phosphorylation is one of the most common types of 
protein posttranslational modification that is nom recognized 
to mediate the response of eukaryotic cells to external  
stimuli (Krebs, 1986). The reaction of phosphorylation is 
catalyzed by protein kinases the enzymes that transfer  
phosphates from phosphoryl donors to acceptor amino acid 
residues of protein substrates, ft is reuerslble. The reuerse 
r e a c t io n ,  I .e .  d e p h o s p h o ry la t io n  is c a ta ly z e d  by 
phosphoprotein phosphatases (Ballou and Fischer, 1986), the 
enzymes that take the phosphates of f  from the acceptor  
res idues  of p ro te in  s u b s t ra te s .  P h o s p h o ry la t io n /  
dephosphorylation reueals a general mechanism by mhich 
different cellular function are controlled. This has not been 
realized until the discouery that glycogen metabolism is 
controlled by phosphorylation (Krebs et al, 1959). Glycogen 
phosphorylase kinase mas the first protein kinase to be 
purified. Folloming the discouery of cyclic AMP-dependent  
protein kinase (lllalsh et al, 1968), the number of enzymes 
that haue been identif ied as protein kinases haue risen 
exponentially (Hunter, 1987). All protein kinases thus far  
characterized mith regard to substrate specificity ( i.e. 
phosphoryl acceptor residues of the protein) fall mithin one of 
tmo broad classes, serine/threonine-specific protein kinases 
(Edelman et a!, 1987) and tyrosine-specific protein kinases 
(Hunter and Cooper, 1985). Protein phosphorylation occurs 
most frequently on seryl and threonyl residues and less 
frequently  on tyrosyl residues (Cooper et al, 1983). The 
discouery of protein tyrosine kinases took place about 20
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years la te r  than that of protein serine/threonine kinases 
(Hunter, 1987). The tmo protein kinases can be fu rther  
c h a ra c te r iz e d  into seuera l  subclasses e.g. pro te in  
serine/threonine kinases can be further diuided into cyclic 
nucleotide-dependent subfamily, Raf-Mos proto-oncogene  
subfamily and casein kinase subfamily etc, and protein  
tyrosine kinases can be further  diuided into Src oncogene 
subfamily, Rbl oncogene subfamily and gromth fac tor  
receptor subfamily etc. Homeuer, all eucaryotic protein  
kinases are euolutionarily related mith common properties 
(Hanks et al, 1988).
2.1. General p ropert ies  of protein  kinases
Rll protein kinases require diualent metal Ions for their  
ac t iu i ty .  Mg++ probably serues as the physiologically  
significant cation in all instances (Krebs, 1986). Many protein 
tyrosine kinases shom an apparent preference for Mn++ ouer 
Mg++ due to indirect inhibition of Mn++ to phosphotyrosine- 
speciflc phosphatases (Hunter and cooper, 1985),  and 
probably Mn++ mimics the action of a physiological actiuitor  
(LUente et al, 1990). RTP Is the preferred nucleotide of  
phosphoryl donor for almost all protein kinase since there are 
RTP recognition sites in the conserued catalytic domain of the 
kinases (Hanks et al, 1988; Soderling, 1990).
Conserued catalytic domain Protein kinases principally haue 
tmo functional domains: a catalytic domain and a regulatory 
domain (Taylor, 1989). The catalytic domain of the kinase lies 
near the carboxyl terminus of the protein, comprising 250 to 
300 amino acids. Of these, some regions are highly conserued
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throughout all the protein kinase family, and some haue louier 
conseruation. Starting from the N-terminus of the catalytic 
domain, the folloiuing consensus motif of Gly-H-Gly-Hz-Gly- 
Hi5- 20-Lys is present in all protein kinases and responsible 
for HTP binding (Hanks et al, 1988). The first tuio Glys and the 
Lys are inuariant residues, but the third Gly residue is 
replaced by Ser or Ala in some instances (Soderling, 1990). Hs 
are nonconserued amino acids. The short sequence Gly-H-Gly- 
H-H-Gly that is also found in many nucleotide-binding proteins 
probabiy serues as a nucleotide fold motif  (Rossman et at, 
1974; lUierenga and Hoi, 1983): It forms an elboLU around the 
nucleotide, mith the first glycine in contact mith the ribose 
moiety and the second glycine lying near the terminal  
pyrophosphate (Sternberg and Taylor, 1984). In tmo positions 
domnstream of the third Gly, there is a highly conserued Ual. 
This ualine residue may contribute to the positioning of the 
conserued glycines (Hanks et al, 1988). The inuariant Lys of 
the consensus appears to be directly inuolued in HTP-binding 
(Taylor, 1989). Since fluorosulfonylbenzoyl 5 -adenosine  
(FSBfl), an analog of RTP, inhibits the function of the catalytic 
domain by coualently modifying this Lys (Zoller et al, 1981), 
mutations at this position result in loss of protein kinase 
actiuity (Hannink and Conoghue, 1985; LUeinmaster et al, 1986; 
Chen et al, 1987; Glenney et al, 1988). About 80-180 residues 
(Hunter, 1987) domnstream from the Lys, there are a series of 
highly conserued short stretches and indiuidual amino acid 
residues separated by regions mith lomer conseruation, 
forming a central core of the catalytic domain. The folloming 
consensus triplets Rrg-Rsp-Leu, Asp Phe Gly and flIa-Pro-Glu
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are of characteristic feature of the centre core. They are 
inuolued in substrate recognition (Hanks et ai, 1988; Taylor,
1989) and enzyme catalysis e.g. the consensus Rrg-Rsp-Leu-  
Lys-Pro-Glu-flsn specifies serine/threonine kinases, hauing a 
re q u i re m e n t  fo r  basic aminoacids p reced ing  the  
phosphorylation site and the consensus Rrg-Rsp-Leu-î\rq-B\^- 
Rla-Rsn (src family only) or Rrg-Rsp-Leu-HlB-H[a-f\rQ-î\sn (all 
others) specifies tyrosine kinases, hauing a requirement for  
acidic residues. The consensus tripiet RIa-Pro-Glu is often  
mentioned as a key protein kinase catalytic domain indicator 
(Hunter and Cooper, 1986). Each indiuidual aminoacid in this 
triplet is required for enzyme actiuity. The Rsps of the first 
and second triplets are also inuolued in RTP-binding (Brenner, 
1987; Buechler and Taylor, 1988). In contrast, the regulatory 
domain of the kinase shoLus no ouerall  euolutionary  
relatedness but the mechanism by mhich the regulatory  
domain maintains the catalytic domain in an inactiue state In 
the absence of ligands appears to be similar.
Substrate recognition It Is common that a single protein can 
be phosphorylated at seueral sites by d if fe rent  protein  
kinases (Cohen, 1985), and a single protein kinase is able to 
phosphory la te  seueral  d i f fe re n t  su b s tra te  proteins  
(Engstrom, 1984). This is determined partially by the primary 
structures of both kinases and their substrate proteins. Rs 
mentioned before, there are substrate recognition sites in the 
conserued kinase catalytic domain, mhich require not only the 
phosphorylatable target  hydroxyamino acid but also the 
neighbourhood amino acids. The ouerall similarity of the 
conserued catalytic domain in the protein kinase family mould
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result in the similarity of substrate selection in each family. 
For protein ser ine/threonine kinases in euery case the 
canonical recognition sequence contains basic residues near  
the serine or threonine e.g. sequence flrg-flrg-H-Ser-V, in 
mhich H specifies any amino acid and Y is a hydrophobic amino 
acid, is specifically fauoured by cRMP-dependent protein 
kinase (Zetterquist et al, 1990). For protein tyrosine kinases, 
usually a sequence that contains acidic residues proximal to 
the target tyrosine is almays beneficial (Geanlen and Harrison,
1990). Homeuer, in addition to primary sequences, there are 
factors that determine the specificities for indiuidual kinase 
in substrate recognition. The secondary an d /o r  te r t ia ry  
structure of the protein is surely an important factor in this 
process. Biological function requirement of the kinase and 
substrate protein could be another factor e.g. substrates for 
uiral tyrosine kinases are of tmo sorts: glycolytic enzymes 
and cytoskeleta l  proteins (Hunter and Cooper, 1986).  
Substrates for cellular tyrosine kinases are mainly three  
types (Glenney, 1991): membrane and cytoskeletal proteins 
such as Ezrin (Bretscher, 1989) and Paxillin (Tumer et al,
1990); serine/threonine protein kinases that regulate the cell 
cycle such as p34cdc2 (Gould and Nurse, 1989) and MRP (M 
phase actiuating protein) (Rnderson et al, 1990a); and SH2- 
domain containing proteins that transduce signals from  
gromth receptors such as PLCy (Phospholipase C y) (Morrison 
et al, 1990) and GRP (GTPase actiuating protein) (Kazlauskas 
et al, 1990).
Rutophosphorylation RImost all protein kinases possess an 
ability to undergo autophosphorylation process, i.e. they
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p h o s p h o r y la t e  î h e m s e lu e s  Ckrebs, 1 9 8 6 ) .  The 
autophosphorylation reaction can be either Intramolecular or 
intermolecular. But the functional meaning of the process is 
not uery clear in many indiuidual case. In general,  
autophosphorylation stimulates kinase actiu ity .  This is 
probably because many enzymes are kept In an inactiue or 
inhibited state by the interactions of their regulatory domain 
and catalytic domain (Taylor, 1989). Rutophosphorylation may 
disrupt the interactions betmeen the tmo domains by inducing 
a conformational change in the enzyme, thereby releasing the 
catalytic domain from the Inhibition of the regulatory domain 
(Soderling, 1990). In cRMP kinase, autophosphorylation causes 
a 10-fold Increase in the dissociation constant of interactions 
betmeen regulatory subunits and catalytic subunits (Scott and 
Mumby, 1985), mhereas in cGMP kinase, the e f fe c t  of 
autophosphorylation on the actiuation of the enzyme is 
mediated by a change in the affinity of the kinase for cyclic 
RMP (Landgra f  et al, 1986).  The re q u ire m e n t  fo r  
autophosphorylation of CaM kinase II (Calcium/calmodulin-  
dependent protein kinase I I )  at Thr-286 is to generate a 
partially Ca++-independent species of the kinase and block the 
inhibitory interactions betmeen the inhibitory domain and the 
RTP-binding site (Colbran et al, 1989; Fong et al, 1989). 
Rutophosphorylation is particularly Important in regulating 
functions of protein tyrosine kinases, and all protein tyrosine 
kinases identified so far  autophosphorylate at multiple sites, 
especially receptor type kinases (Hunter and Cooper, 1985; 
1986). One major autophosphorylation site mhich is highiy 
conserued throughout the family is present in the central core
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o f  the  c a ta ly t ic  dom ain  (Hanks et al,  1988 ) .  
Rutophosphorylation of this site In ppBQc-src (corresponding to 
Tyr-416)  controls its kinase and transforming actiuity  
(Pimnica-LUorms et al, 1987; Kmiecik and Shallouiay, 1987). In 
the PDGF receptor, autophosphorylation of Tyr-751, mhich Is 
located mithin the insert region, regulates interactions of the 
receptor mith cellular substrates (Kazlauskas and Cooper, 
1989). In EGF receptor, autophosphorylation appears to 
facilitate a conformation that is competent to interact mith 
and p h o s p h o r y la t e  c e l l u l a r  s u b s t r a t e s  s ince  
autophosphorylation sites of the receptor compete mith 
exogenous substrates for the substrate binding site of the 
kinase (Honegger et al, 1988).
Oncogene products Oncogenes mere originally thought to be 
retrouirus-encoded genes that induced tumors in birds and 
rodents, but haue nom been shomn to be deriued from normal 
cellular genes that haue been picked up by retrouirus and 
genetically damaged (Bishop, 1991). They are dominant  
mutated forms of host genes (colloquially termed proto­
oncogenes). Oncogenes encode a large number of proteins 
that fall into seueral classes (Table.1.) including gromth 
factors and their receptors, membrane-associated mutant  
proteins, and cytoplasmic & nuclear oncoproteins (Hunter, 
1991). Surprisingly, many cellular protein kinases, particularly 
tyrosine kinases, are found to be homologous to many of 
these oncoproteins on the list (Table.1.). They are 
actually uiral kinases or matant forms of cellular kinases 
encoded by oncogenes that are deriued from normal kinase 
genes (Hunter and Cooper, 1986; Yarden and Ullrich, 1988;
21
Hunter, 1991). Thus the tiuo kinases (uiral and th e ir  
counterpart cellular) are genetically related homologues. They 
haue the same kinase actiuity. This implicates the role that  
phosphorylation especiaily tyrosine phosphorylation plays in 
cell transformation.
Table 1. Functions of Cell-Derived Oncogene Products
Class 1 —Growth Factors
sis PDGF B-chain growth factor
int-2 FGF-related growth factor
hst (KS3) FGF-related growth factor 
FGF-5 FGF-related growth factor
int-1 Growth factor?
Class 2 —Receptor and Nonreceptor Protein-Tyroslne Kinases
src Membrane-associated nonreceptor protein-tyrosine
kinase
yes Membrane-associated nonreceptor protein-tyrosine
kinase
fgr Membrane-associated nonreceptor protein-tyrosine
kinase
Ick Membrane-associated nonreceptor protein-tyrosine
kinase
fps/fes Nonreceptor protein-tyrosine kinase
abt/bcr-abt Nonreceptor protein-tyrosine kinase
Table 1. Continued.
ros
orbB
nou
fms
met
irk
Membrane associated receptor-like protein-tyrosine 
kinase
Truncated EGF receptor protein-tyrosine kinase 
Receptor-like protein-tyrosine kinase 
Mutant CSF-1 receptor protein-tyrosine kinase 
Soluble truncated receptor-like protein-tyrosine 
kinase
Soluble truncated receptor-like protein-tyrosine 
kinase
kit (IV locus) Truncated stem cell receptor protein-tyrosine kinase 
sea Membrane-associated truncated receptor-like
protein-tyrosine kinase 
ret Truncated receptor-like protein-tyrosine kinase
Class 3— Receptors Lacking Protein Kinase Activity 
mas Angiotensin receptor
Class 4—Membrane-Associated G Proteins
H-ras Membrane-associated GTP-binding/GTPase
K-ras Membrane-associated GTP binding/GTPase
N-ras_______Membrane-associated QTP-binding/QTPase________
gsp Mutant activated form of G, a
gip Mutant activated form of Gj a
Class 5—Cytoplasmic Protein-Serine Kinases
raf/mil Cytoplasmic protein-sorine kinase
pim-1 Cytoplasmic protein-serine kinase
mos Cytoplasmic protein-serine kinase (cytostatic factor)
cot Cytoplasmic protein-serine kinase?
Class 6 —Cytoplasmic Regulators 
crk SH-2/3 protein that binds to (and regulates?) 
phosphotyrosine-containing proteins
Class 7—Nuclear Transcription Factors
myc
N-myc
L-myc
myb
iyi-1
p53
fos
fun
ertoA
rei
vav
ets
ski
evi-1
gli-1
mat
pbx
HOX2.4
Unclassified
dbi
bci-2
Sequence-specific DNA-blnding protein 
Sequence-specific DNA-binding protein? 
Sequence-specific DNA-binding protein? 
Sequence-specific DNA-binding protein 
Sequence-specific DNA-binding protein?
Mutant form may sequester wild-type p53 growth 
suppressor 
Combines with c-jun product to form AP-1  
transcription factor 
Sequence-specific DNA-binding protein; part 
of AP-1
Dominant negative mutant thyroxine (T3) receptor 
Dominant negative mutant NF-xB-related protein 
Transcription factor?
Sequence-specific DNA-binding protein 
Transcription factor?
Transcription factor?
Transcription factor?
Transcription factor?
Chimeric E2A-homeobox transcripton factor 
Transcription factor?
Cytoplasmic truncated cytoskeletal protein? 
Plasma membrane signal transducer?
Table.1. Functions of ceil-derlued oncogene products 
(from Hunter, 1991).
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2.2. Functions of protein  phosphorylation
Protein phosphorylation is noui recognized as a uniuersal 
control mechanism that regulates eukaryotic cell functions. It 
inuolues the control of signalling pathiuays that allouj the cell 
to respond to external stimuli and is inuolued in the control of 
intramolecular biochemical changes that are required for cell 
gromth and diuision. Because many oncogene products are 
m utan t  forms of protein  tyrosine kinases, tyrosine  
phosphorylation Is closely related to cell transformation. 
Control of cell cycle R cell cycle is defined as a period during 
mhich a series of important euents required for successful 
cell reproduction are completed. Tmo hallmarks of cellular 
reproduction are chromosomes replication in S-phase (Laskey 
et al, 1989) and mitosis (the replicated chromosomes are 
segregated into tmo daughter cells) in M-phase (McIntosh and 
Koonce, 1989). Thus entry to S-phase and M-phase are tmo 
restriction points that gouern the cell cycle. It is nom clear 
that the entry to M-phase is controlled by a key regulator  
originally named maturation promoting factor (MPF) but nom 
considered as M phase promoting factor or M phase kinase, 
since actiuated MPF phosphorylates histone HI and other  
important proteins, leading to the major euents of M-phase  
(Murray and Kirschner, k1989; Ooree, 1990). MPF consists of 
tmo distinct components: a catalytic subunit of a 34K protein 
kinase from cdc2 (p34cdcz) and a regulatory subunit called 
cyclin because of its cyclic appearance (Lemin, 1990). p34cdc2 
is a homologous product of cell diuision cycle gene 2 (cdc2) 
from fission yeast Schizosaccharomyces pombe (S pombe) but 
conserued In all eukaryotic cells (Pines and Hunter, 1990). It is
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a protein serine/threonine kinase and Its actiuity Is itself  
regulated by phosphorylation and dephosphorylation on 
tyrosine and threonine residues, i.e. being actiue mhen 
dephosphorylated and inactiue mhen phosphorylated (Draetta 
et al, 1988; Moria et al, 1989). Actiuation of p34cdc2 being 
dephosphorylated) Induces M-phase mhereas exit from M -  
phase requires in a c t iu a t io n  of p3 4 cdc2 being
phosphorylated again) (Nurse, 1990).
Signal transduction fl common mechanism by mhich external 
stimuli such as gromth factors, differentiation factors and 
hormones regulate cellular proliferaton and differentiation Is 
through transmembrane receptors mith Inducible protein-  
tyrosine kinase actiuity (Ullrich and Schlesslnger, 1990). 
Binding of these receptors to their specific ligands results In a 
conformational change in the extracellular domain of the 
receptors, mhich In turn transmit across the membrane to 
their  cytoplasmic domain that contains a tyrosine kinase 
catalytic domain by oligomerization (Schlesslnger, 1988) or 
dimerlzation (Seifert et al, 1989; Heldin et al, 1989). Cross- 
p h o s p h o ry la t lo n  then  occurs In t r a m o le c u la r ly  or  
Intermolecularly on multiple tyrosine residues, alloming 
further change of conformation that enhances kinase actiuity 
tomard other substrates and prouides binding sites for SH2 
domain containing proteins (Cantley et al, 1991). The SH2 
domain (Koch et al, 1991 )-contalnlng proteins are a series of 
cytoplasmic signalling molecules that all contain a region 
named src homology region 2 (SH2). Since this region is 
homologous to a conserued noncatalytic region of src tyrosine 
kinase family (SacomskI et al, 1986; Pamson, 1988), the SH2
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domain binds to a tyrosine-phosphorylated protein (Rnderson 
et ai, 1990; Mayer et a l ,1991), and different SHZ-containing 
molecules mould recognize different phosphotyrosine sites 
(FantI et ai, 1992). The binding of receptors to SH2 domain- 
containing proteins results In the formation of heteromeric  
protein complexes at or near the plasma membrane, mhich 
mould Initiate further response to the external stimuli along 
the signal transduction pathmays (Cantley et at, 1991). The 
nonreceptor family of Src tyrosine kinases mediate signal 
transduction ula the SH2 domain by phosphorylating the 
target protein first (Cantley et al, 1991). Thus it Is likely that 
tyrosine phosphorylation acts as a smitch that controls the 
actiuation of signal transduction pathmays.
Cell transformation Tyrosine-specific protein kinase actiuity 
mas first discouered In cells transformd by Rous Sarcoma 
Uirus (Collett and Erlkson, 1978; Hunter and Sefton, 1980). 
Since then many protein tyrosine kinases haue been 
discouered as oncogene products (Hunter, 1991 ) and their  
Importance in regulating cell functions has been reuealed only 
through the study of oncogene and protooncogenes (Bishop,
1991). So It is not surprising that tyrosine phosphorylation is 
deeply Inuolued In cell transformation. Both oncogenes and 
their counterpart proto-oncogenes send their signals through 
the same pathmays in a similar manner (Cantley et al), UJhen 
the oncogene becomes dominant,  the normal negatlue  
regulatory control of cellular tyrosine kinases appears to be 
abrogated. Oncogenes deriued from receptor tyrosine kinases 
such as u-erbB (from EGFR) and u-kit (from PDGFR), or encode 
mutant proteins that associate mith the inner face of the
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cytoplasmic membrane such as u-Src and u-Ras, prouide a 
continuous l igand-independent mitogenic signal (Hunter,
1991); Oncogenes that encode mutant forms of cytoplasmic 
protein serine/threonine kinases transform cells by acting on 
check points of the cell cycle (Hunter, 1991) e.g. c-Mos  
(coding for a protein serine kinase) and stabilizes the actiuity 
of MPF and is inuolued in the mechanisms by mhich cells are 
preuented from entering mitosis mhen they are too small or 
mhen DNR synthesis has not been completed (Sagata et al, 
1989a; 1989b). In contrast u-Mos driues cells into mitosis by 
accelerating the actiuation of the cyclin-cdcZ complex.
3. Rdenouirus DNR-binding protein  (OBP)
The adenouirus ONR-binding protein (OBP) is a gene 
product of early region E2R. I t  is a mult i funct ional  
phosphoprotein mhich is produced In large quantities and 
accumulates In the nuclei of Infected cells at both early and 
late times (Rxelrod, 1978; Sugamara et al, 1977; UoelkerdIng 
and klessig, 1986). BBP contains 529 amino acid of knomn 
sequence but has an apparent molecular meight of 72K upon 
SOS-polyacrylamlde gel electrophoresis (Kruijer et al, 1982). 
Genetic and mutation analyses haue shomn that OBP contains 
tmo functional domains (Rice and Klessig, 1984) mhich can be 
separated by mild chymotrypsin treatment (Klein et al, 1979; 
Lînne and Phllipson, 1980). The N-termlnal domain, consisting 
of about one-third of the molecule (residues 1-173), Is poorly 
conserued but highly phosphorylated. It does not bind to DNR. 
Mutations in this part of the protein affect the host range of
26
the uirus and uiral late gene expression (Klessig and 
Grodzicker, 1979; Rnderson et al, 1983; Brough et al, 1985). 
The N-termlnal domain is also uery rich in proline residues and 
contains a high content of both basic and acidic amino acids. 
Tmo short stretches of basic amino acids 42 -46  and 84-89  
haue been defined to be inuolued In nuclear transport of DBF 
(Morin et al, 1989a). In contrast, the C-terminal domain, 
consisting of tmo-third of the molecule (residues 174-529), is 
poorly phosphorylated but highly conserued (Kitchingman, 
1985; Uos et al, 1988). DNR and RNR binding actiuity of the 
protein is confined to this domain (Klein et al, 1979; Cleghon 
and Klessig, 1986). The roles that DBF plays in uiral DNR 
replication also appear to be confined to this domain (Friefeld 
et al, 1983; Tsernoglou, 1985). Mutations In this part of the 
protein display a DNR replication deficient phenotype (Kruijer 
et al, 1983).
3.1, Phosphorylation o f  OBP
DBF is phosphorylated during the course of infection 
since In uiuo labelling of Rd5 Infected HEK cells mith 3ZP 
résolues a phosphorylated polypeptide of apparent molecular 
meight 72K afte r  SDS PRGE analysis (Russell and Blair, 1977). 
Most phosphorylation sites of OBP are located at the N- 
terminal.  This is demonstrated by labelling of adenouirus 
Infected cells mith both and /n yiyg  follomed by 
chymotrypsin cleauage (Klein et al, 1979; LInne and Phllipson, 
1980) and by amino acids mapping (Rnderson et al, 1985). Rll 
phosphorylation sites found In DBF are on the serine and 
threonine residues (Linne et al, 1977; Rxelrod, 1978). Homeuer
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one tyrosine at C-terminal is found to be phosphorylated 
early a f te r  infection (Russell et al, 1989). Bacterial alkaline 
phosphatase treatment of DBP remoues 90-95% phosphate 
groups from phosphoserines and phosphothreonines (Klein et 
al, 1979), and reduces apparent molecular meight of OBP from 
72K to 70K. This suggests that most of the phosphate 
associated mith DBP is sensitiue to alkaline phosphatase and 
the Increase of the 2K In apparent molecular meight of DBP Is 
due to posttranslational modification of phosphorylation  
(Linne and Phllipson, 1980). The bond betmeen the phosphate 
moiety and the protein is shomn to be alkali-labile (Rxelrod, 
1978), suggesting a monoester linkage of the phosphate to 
hydroxyl groups of serine and threonine residues (Linne et al, 
1977). DBP can be phosphorylated in uitro  by a m ajor  
chromatin-associated protein kinase from uninfected Hela 
cells (Klein et al, 1979), mhich phosphorylates H-1, H-2a, and 
H-4 histones (Schlepper and Knipprs, 1975), and is nom knomn 
as a protein serine/threonine kinase p34cdc2 (Draetta et al, 
1988; Rrion et al, 1988). It has been proposed that the uarlous 
phosphorylated forms of DBP may carry out the d ifferent  
roles of this multifunctional protein. But only the effect of 
this posttranslational modification on DNR binding has been 
directly tested (Linne and Phllipson, 1980; Klein et al, 1979). 
Some re su l ts  suggest th a t  p h o s p h o ry la te d  and 
dephosphorylated DBP bind to single-stranded DNR mith the 
same efficiency (Linne and Phllipson, 1980), mhlle some 
results suggest that dephosphorylated DBP binds to DNR more 
t ightly than phosphorylated DBP does (Klein et al, 1979). 
Homeuer, mutations that  subst i tute  more than eight
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phosphorylation sites of DBP alter  Its ability to enhance its 
OLun synthesis mhereas substituting one or a fem of these 
sites has little effect on it (Morin et ai, 1989b), suggesting 
that the ouerall phosphorylation state of the protein may be 
Important for enhancing Its omn expression.
3.2. Nucleic acid binding ac t iu i ty
Rdenouirus DBP mas first isolated by its strong binding to 
single-stranded DNR (uan der Uliet & Leuine, 1975) and thus 
classified as a single-stranded DNR (ssDNR) binding protein 
(Chase & liJilliams, 1986). But It also binds to double-stranded 
DNR (dsDNR) as melt as RNR (Fomlkes et al, 1979; Cleghon and 
Klessig, 1986). The binding of DBP to ssDNR Is cooperatiue mith 
no apparent sequence specificity (Schechter et al, 1980). 
ssDNR couered mith DBP has a regular and locally extended 
configuration, inducing a considerable tilt of the bases (uan 
Rmerongen et at, 1987). The size of binding sites Is 10-15  
nucleotides from circular dichroism spectroscopy (Kull et al, 
1989) and 16 nucleotides from a spectrofluorometric study 
(Meyers et al, 1990). In contrast the binding of DBP to dsDNR 
is noncooperatlue mith similar affinity as to ssDNR, forming a 
multimeric complex (Stuiuer and uan der Uliet, 1990). Double 
stranded DNR complexed mith DBP has a rigid structure and is 
unable to fold back on itself (Stuiuer et al, 1992). DBP remoues 
ter t ia ry  structures from dsDNR and introduces changes in 
base-to-base positions in dsDNR. The characteristic of the 
complex is that DBP rapidly dissociates from dsDNR. The 
complete dissociation occurs mithin one minute at room 
temperature (Stuiuer et al, 1992). In contrast, dissociation of
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DBP from ssDNR is much siouier, indicating a d if fe rent  
interaction betuien DBP-ssDNR and DBP-dsDNR. DBP binds to 
RNR in a similar cooperatiue manner as to ssDNH (Cleghon and 
Klessig, 1986). R uariety of approaches haue been used to 
localize the nucleic acid binding region. Limited chymotrypsin 
digestion gen era te  tmo distinct f ragm ents  and the  
nucleotides binding actiuity of DBP Is confined to Its C- 
terminal domain mhich contains four conserued regions (CR) 
defined from sequence comparatiue analysis as CR1 (amino 
acids176-186), CR2 (amino acids 323-330),  CR3 (amino acids 
464 -4 75 )  and a zinc finger domain (amino acids 273-286)  
(Kitchingman, 1985; Uos et al, 1988). Mutagenesis studies on 
these regions suggests that CR3 and to a lesser extent CR2 
are inuolued In the DNR-bindIng (Neale and Kitchingman, 
1989;1990). R zinc finger (Berg, 1990; Bailee, 1991) binding 
study of DBP suggests that this motif  is required for DNR- 
binding (Uos et al, 1988a) and the conserued region (amino 
acids 273-286) that mediates zinc binding is fundamental for 
DNR-blndIng (Eagle and Klessig, 1992).  Study from  
photochemical cross-linking suggests that methionine 299 
and phenlalanlne 418 are probably tmo contact points 
(tyrosine 455 could be a third possible site) betmeen DBP and 
DNR (Cleghon and Klessig, 1992). Deletion of the C-terminal 46 
amino acids abolishes DNR binding. It  can be concluded from 
these results, that the precise DNR-binding sites in DBP are 
still a question, although they appear to be mithin or near the 
conserued regions In the C-terminal of the protein.
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3.3. The roles m DNB replica t ion
DBP is one of the three uiral proteins required for DNR 
replication in both Initiation and elongation. DBP stimulates  
in it iat ion reaction uia NFI and cooperates mith pol to 
elongate the initiated DNfl chain.
In i t i a t io n  Init iat ion of DNfl replication In prokaryotes  
(Kornbrg, 1988) as melt as in eukaryotes (Hay and Russell, 
1989; Challberg and Kelly, 1989) requires a preinit iation  
complex that is formed and stabilized by protein-DNR and 
protein-protein interactions at the origin of DNfl replication. 
The formation of such a complex In adenouirus type 2 DNR 
replication requires the binding of nuclear factor I (NFI) to its 
recognition sites at the origin (Chen et al, 1990). NFI is 
presumed to promote initiation by its binding to DNR and Its 
interactions mith pol at the origin (Bosher et ai, 1990). The 
role DBP plays here Is that it increases the affinity of NFI for  
its binding sites at the origin and it also increases the rate of 
association and decreases the rate of dissociation of NFI mith 
the DNR template (Cleat and Hay, 1989). The enhancement of 
NFI-binding by DBP is probably through the interactions of DBP 
mith DNR rather than NFI since no direct contact betmeen DBP 
and NFI has been found and preincubation of DNR mith DBP 
results in a similar effect (Stuiuer and man der Uliet, 1990). 
DBP forms a multimeric complex mith double-stranded DNR in 
an apparent ly  noncooperatlue fashion, thus inducing 
structural changes in DNR and facilitating the binding of NFI 
as mell as the Initiation of DNR replication uia NFI (Stuiuer et 
al, 1992). Homeuer, in the absence of NFI, DBP itself  can still
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stimulate the frequency of the Initiation reaction (Temperly 
and Hay, 1991).
Elongation DBP has tmo functions in elongation. One Is to 
coat the displaced single-stranded DNR as a single-stranded 
DNR-binding protein, thereby most likely protecting it from 
nuclease digestion (uan der Uliet et al, 1978). The other is to 
Increase the processiuity of pol as a specific cooperater in 
DNR chain synthesis (Lindenbaum et ai, 1986). In the first role, 
DBP could be replaced by other single-stranded DNR-binding 
proteins, but In the second role it absolutely requires the 
presence of adenouirus DBP. Rfter initiation, pol dissociates 
from pTP and associates mith DBP, forming a complex 
(Lindenbaum et al, 1986). In this complex, DBP stabilizes pol 
and facil i tates pol translocating through the duplex DNR 
template since Rd pol is Incapable of translocation through 
regions of secondary structure.
3.4. The roles In transcript ion
The functions of DBP in gene transcription are not as clear 
as in DNfl replication. Homeuer, in general, DBP has a negatlue 
effect on early gene transcription and a positiue effect  on 
late gene transcription.
Early gene transcr ip t ion  DBP is responsible for the 
accumulation of early mRNRs by decreasing the half life of 
some early mRNRs (Babich and Neuins, 1981) and by inhibiting 
transcription from the E4 promoter (Handa et al, 1983). R 
te m p e ra tu re -s e n s i t iu e  m utant  of adenouirus type 5 
(H5ts125), mhich is restricted to the early phase of infection 
mhen gromn at the nonpermissiue temperature (Ensinger and
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Ginsberg, 1972) and maps to the E2fl that codes for DBP, 
ouerproduces early uiral mRNfls at the nonpermissiue  
temperature (Carter and Blanton, 1978), suggesting a loss of 
function of DBP that controls the abundance of the early 
mRNRs of the uirus. Pulse-labelling during H5 ts125 infection 
shoujs that E4 transcription is repressed at the permisslue 
tem pera ture  but not at the nonpermissiue tem perature  
(Neuins and IDinkler, 1980), suggesting a repression function 
of DBP to the transcription from E4 region. Furthermore, the 
repression of E4 transcription results from a block of 
in i t ia t ion  r a th e r  than an Inducement of  p re m a tu re  
termination of transcription. I.e. DBP acts directly on the E4 
promoter. Preincubation of uiral DNR fragments mith purified 
DBP specifically inhibits the transcription from the E4 
promoter, mhile addition of single-stranded DNR significantly 
reduces the inhibition of DBP for the E4 promoter (Handa et al, 
1983), implying a specific effect of DBP on E4 transcription. In 
contrast, DBP stimulates the transcription from ElR and E2R 
promoters (Chang and Shenk, 1990; Morin et al, 1989b).
Late gene transcription DBP stimulates the transcription 
directed by the m a jo r  late  p rom oter  (MLP) and the  
stimulation of DBP to MLP Is about three fold greater  than 
that of El R transactiuator protein (Chang and Shenk, 1990). R 
mutation in the E2R gene encoding the DBP (Klessig and 
Grodzicker, 1979) enhances the normally depressed leuel of 
adenouirus late transcription in monkey cells (Johnston et al, 
1985). These results suggest that DBP plays a central role in 
late gene transcription.
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4. flîms of this mork
Hdenoüiruses serue as model systems for studying uirus- 
cell relationships and eukaryotic regulation since they are 
uery easy to maintain in standard tissue culture. The 
adenouirus encodes a nonstructural multifunctional DNA- 
binding protein (DBP) mhich is produced in large quantities at 
both early and late times of infection. I t  is euident that DBP 
plays many important roles during uirus multiplication and It 
has been knomn for  some time that  DBP is heauily  
phosphorylated during infection. Preuious experiments also 
shom the presence of a phosphotyrosine residue in DBP 
(Russell et al, 1989). Protein phosphorylation Is belieued to be 
a key mechanism in regulating uarious functions or actiuities 
of a protein. Protein tyrosine phosphorylation especially has 
been knomn to haue a close relation to uiral transformation  
and cell proliferation. Homeuer no specific functions of DBP 
haue been found so far to be attributed to its phosphorylation 
state. Particularly it has not been confirmed that DBP is 
phosphorylated at a tyrosine residue. Thus the purpose of this 
mork is to inuestigate phosphorylation euents, particularly 
tyrosine phosphorylation of DBP in an in uitro system and its 
relation to uarious functions of DBP by :
(a) Preparing antibodies against phosphotyrosine and DBP 
to detect phosphotyrosine in DBP and to characterise 
the phosphorylation state of DBP.
(b) Constructing an expression uector to carry out site 
directed mutagenesis on DBP in order to inuestigate 
uarious functions that are ascribed to DBP at the 
molecular leuel.
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Part I Preparing antibodies against 
phospiiotgrosine and DBP
Monoclonal antibody (MHb) techniques haue been mell 
established and deueloped since Kohler and Milstein first  
achieued their  preparation in 1975 (Kohler and Milstein, 
1975). The principle inuolued is: An antibody secreting cell (B- 
iymphocytes from immunized animal) produces only one 
particular antibody molecule and Is not able to be gromn in 
culture but if it is fused mith a tumour cell mith continuously 
groming and non-secreting characteristics, then the hybrid 
cell can secrete the desired antibody and be gromn in culture 
and in uiuo to produce large amounts of MAb.
Methods:
1. Preparat ion  o f  immunogens
The immunogens used in Immunizing rabbits and mice 
mere Ptyr-KLH conjugate and purified DBP.
Coupling of phosphotyrosine (Ptyr) to a protein carrier 
KLH (Hemocyanin from Keyhole Limpets) or to BSA (Bouine 
serum albumin): 10|iM (2.6mg) of 0-phospho-L-tyrosine (Ptyr, 
Sigma) mas dissolued in 1.8ml of 0.1M PBS (PH 7.5) and IB^M 
(3.1 mg) of SPDP (N-Succinlmidyl 3 - ( 2 -p y r id y ld i th io )  
propionate, Pierce) mas dissolued in 200|il of ethanol. The 
200]Lil SPDP solution mas added dropmise to the 1.8ml stirred 
phosphotyrosine solution to giue a final concentration of 5mM 
of Ptyr-SPDP conjugate (Ptyr and SPDP mere reacted at 1:1 
molar ratio). The reaction mixture mas left for half an hour at
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room temperature mith occasional stirring. lOmg KLH (Sigma) 
mas dissolued in 3ml of 0.1M PBS at PH 7.5, then added into 
Ptyr-SPDP mixture and left for a further 2 hours. The reaction 
mixture mas transferred  to 4^0 ouernight and dialysed 
against PBS for 24 hours to remoue excess reagent (Carlsson 
et al, 1978). Ptyr BSD conjugate mas prepared by the same 
procedure.
Alum precipitation of Ptyr-KLH and DBP for immunizing mice: 
In the case of Ptyr-KLH conjugate, 100p1 of IM  NaHCOs (BDH) 
mas added to 1ml of Ptyr-KLH (1 m g/m l)  and mixed by 
uortexing.l00|il of 10% Aluminium Potassium Sulphate (Sigma) 
mas added dropmise mhile uortexing. The mixture mas 
pelleted at 500g for 10 min (MSE bench centrifuge) and the 
pellet mas mashed in PBS three times and resuspended In 1ml 
of sterile saline (Chase, 1967).
In the case of purified DBP (prepared by Ian Leith from Ad2 
infected HeLa cells), 22.8ml of 0.25N NaOH mas added 
dropmise to 10ml of 10% Aluminium Potassium Sulphate in a 
50ml conical tube by uortexing. After 10 min incubation at 
room temperature, the mixture mas centrifuged at 500g for  
10 min (MSE) and the pellet mas mashed once mith distilled 
mater and resuspended in 10ml of sterile saline and added to 
200^il of DBP (1|ag/jLil) in a 1.5ml Eppendorf tube. After  
incubation at room temperature for 30 min, the precipitate  
mas pelleted in bench microcentrifuge (500g, 10 min) and 
resuspended in 1 ml of sterile saline.
Adding Freund's ad iuuants to Ptyr-KLH and DBP for  
immunizing rabbits: 1ml of Freund's complete or incomplete 
adjuuant mas added into 1ml of Ptyr-KLH ( Im g /m l)  conjugate
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or purified DBP (Q.5mg/nnl) in a 5ml Bijou and the mixture mas 
emulsified by sonicating on ice.
2. Im m unizat ion  of animais
Rabbits (Dutch) mere immunized uia the intramuscular route 
mith 0.5mg of Ptyr-KLH conjugate or 0.25mg of purified DBP in 
an equal uolume of complete Freund's adjuuant and boosted 
mith the same amount of antigen in incomplete Freund's 
adjuuant at 3 meek internals 3 times. R final booster mas 
giuen by intrauenous injection mithout adjuuant. Three days 
after  the final immunization, the serum after  ear bleeding of 
the rabbit mas tested by ELISA.
Mice (Balb/c) mere immunized intraperitonally mith 100^g of 
Ptyr-KLH or 2fà\xq of purified DBP in the adjuuant of alum 
precipitate by the same procedure. Three days a f te r  final 
immunization, the sera from tail bleeding the mice mere 
tested and the spleen mas remoued during the next 1-2 days 
from the mouse mhich gaue the strongest serum response.
3. ELISA test on antisera (Catty and Raykundalia, 1989)
A 96-mell plate mas coated mith ptyr-KLH and KLH alone 
or crude extracts from Ad2 infected Hela cells at the 
concentration of 10|ig/ml ouernight at 4°C and blocked mith 
200|il/mell PBS containing 5% Maruel for half an hour at 37«C. 
Antisera from infected animals mere double-diluted In PBS/5% 
Maruel applied to the plate at 50-100|il/mell and incubated at 
37°C for 1-2 hours. The plate mas mashed 2 times mith PBS 
and follomed by another hour's incubation of horseradish 
peroxides (HAP) labelled goat anti-rabbit  (or mouse) IgG
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(Sigma) diluted 1:1000 5000 in PBS/5% Maruei. Rfter mashing 
ujith PBS 5 t imes, 100|liI o f  0 -p h e n y  ie n e d ia m in e  
dihgdrochloride (OPD, Sigma) solution (4mg GPD/10mi 0.15M 
sodium citrate buffer  at pH 5,6/5iliI H2O2) luas added to each 
Luell and the plate mas left in the dark for 15 30 min to aiiom 
color deueloping. The results mere uisualized by eye or read 
at 492nm on a colorimetric piate reader.
4.  Generation of hybrid cell lines
Preparing macrophages R mouse to be used mas sacrificed in 
an ether j a r  and cleaned mith 70% ethanol. 5mi of premarmed 
( 370C) G-MEM (Giasgom modified Eagie medium)/10% NCS 
(nemborn calf serum) mas injected intraperitoneally into the 
mouse and the abdomen mas massaged gently mith tmo 
fingers at the sides. The organs of the mouse mere roiled to 
the back and the inside fluid mas squeezed from the sides to 
the middle and top of the abdomen and collected by piercing 
through the skin using a 18-G needle (the liquid dripped out to 
a tube). Rbout 3-5ml of fluid (containing macrophages) mas 
collected from one mouse. The macrophages mere pelleted at 
1200 rpm for 5 min (MSE bench centrifuge) and resuspended 
in 20-30m l HRT (hyponanthine/aminopterin/thymidine, 50k, 
Sigma)/G-MEM/10% NCS.
Preparing myeloma ceils Sp2/0 murine myeloma cells 
(Schulman et al, 1978) mere maintained in G-MEM/10% NCS in 
a humidified CO2 incubator at 37°C, being split 1:5 euery 2 -3  
days. For fusion, the cells mere gromn to 90% confluent and 
changed to fresh medium one day before the fusion. Prior to 
fusion the cells mere mashed once mith NCS free G-MEM
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medium, once uiith PBS then resuspended in 5ml of PBS and 
counted.
Preparing spleen cells spleens mere remoued from tmo mice 
and put into a boiling tube containing 5ml of PBS. The spleens 
mere squeezed gently against the tube mall using a pestle to 
release the cells. After standing for 5 min, the suspension of 
spleen cells mas transferred to a 10ml centrifuge tube using a 
pasteur pipette and the spleen cells mere pelleted and 
resuspended in 5mi of 0.83% NH4CI to lyse the red cells. Set 
for 5 min, 3-4mi of calf serum mas carefully underlaid and 
cells mere pelleted again, then resuspended in 5m! of PBS and 
counted.
Fusion Myeioma ceiis mere mixed mith spieen celis at a ceii 
ratio of 1:2-5 in a 50ml centrifuge tube and PBS added to 
50mi. After spinning at 1200 rpm for 5 min, the supernatant 
mas poured off  and the tube mas inuerted to remoue all the 
liquid. Tapped gently to loose the ceils, 0.5mi of premarmed 
PEG 1500 solution (50% of polyethylene giycoi 1500 in 75mM 
Hepes at pH 7.5, Boehringer Mannheim) mas added to the tube 
and mixed mith ceiis by quickly centrifuging at 1200 rpm 
(taken up to 1200 rpm then turned domn immediatly). After  
resuspending the cells, the tube mas immersed in a 37°C 
mater bath and held there for 20 sec mith gentle smirling. 
10ml of G-MEM/10% NCS mas then slomly added in drops In 2 
min time mhile the tube mas smirling. Another 10mi of the 
same medium mas added aftermards ouer 1 min. The fused 
ceils mere pelleted and resuspended carefully in 5mi of HAT 
medium. Mixed gently, sufficient HAT medium mas added to 
make the concentration of cells at 2x105 ceils/ml. 100pt of
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cell suspension mas dispensed into each mell of 96-meli  
tissue culture plate in mhich IQOjii of macrophage suspension 
had been added one day ahead. Peripheral mells of the plate 
mere filled mith PBS or HgO. Hybrid ceiis mere gromn in HRT 
medium fo r  2 meeks a f t e r  fusion then mowed to HT 
(hypoxanthine/thymidine, Sigma) medium for a further 3-4  
meeks before being maintained in medium (G-MEM/10% NCS).
5. Cloning and haruesting
Screening Screening for antibody-secreting hybridomas 
started about 2 meeks a f te r  and ELiSR mas chosen as a 
screening assay system for its simplicity and speed. For anti-  
Ptyr MAh, the Ptyr-BSA conjugate mas used as a coating 
antigen. For anti-DBP MAh, Ad2 infected Heia ceii extract  
(prepared as described in section i - 6) mas used as a coating 
antigen in early stage and purified BBP mas used in late stage. 
50|al of neat supernatant from a 10-50% confluent culture 
mas applied to each antigen-coated mell.
Subcloning AH antigen-specific antibody-secreting hybridomas 
determined from ELISA mere transferred mith supernatant in 
neat to 1:10 dilution to a 24-mell culture plate In mhich 0.5mi 
of macrophage suspension had been added to each mell one 
day ahead. These hybridomas mere tested again for their  
specific antibody secreting in about 5-7 days time (70%-90%  
confluent). Positiue cultures mere then subcloned to 96-mell  
culture as foiioms (modified from Boeye, 1986): the number of 
cells per milliliter in the hybridoma culture mas determined 
using a Burker cell counting chamber and a 1:10 series dilution 
mas then made to a final density of 20 cells/ml, 100^1 of
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mhich mas dispensed to each mell (containing 1 Q Q ] l i I  of 
macrophage suspension in nomal medium). After about 2-3  
meeks, the hybridoma cells mere screened again and the 
positiue culture mas subcioned to 96-mell plate as before to 
ensure a single-cell clone.
Making ascitic fluid Specific antibody-secreting hybridoma 
cells mere gromn in 24-mell  plate to 90% confluent and 
mashed tmice mith PBS, resuspended in 0.5mi of PBS and 
injected into mice to produce ascitic fluid mhich mas collected 
after  2 meeks.
6 , C h arac ter iza t ion  of antibodies by Immunoassay  
Cells, cell extracts and uirus Hela spinner cells mere gromn in 
suspension in Giasgom S-MEM/7% NCS at 37°C and Hela 
monolayer cells mere gromn in G-MEM/10% NCS in a CO2 
incubator at 37»C. They mere maintained by splitting at 1:5 
euery 3 days.
Ad2 infected and uninfected Hela cell extracts mere prepared 
as foHoms from both spinner and monolayer cells depending 
on the requirement: 1000ml of Hela spinner cells (about 5x105 
ceils/ml) or 1 flask (90% confluent) of Hela monolayer cells 
mere infected mith 20 p.f.u/cell of Hd2 in 1/10 original uoiume 
of S-MEM or G-MEM supplemented mith 1% NCS. After 1 hour 
absorption at 37°C, MEM/1 % NCS mas added to original 
uoiume to maintain the cells. UJhere required, 0.5M  
hydroxyurea (Sigma) mas added to 10mM at this stage to both 
infected and uninfected ceils. Ht 12-72 hours post-infection 
(p.I.) the cells mere pelleted, mashed in PBS, resuspended in 
1/100 original uoiume of lysis buffer (20mM Tris-HCI, 0.65M
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NaCI, Im M  EDTR, 0.5% NP40, Im M  PMSF, 10)liM ZnSÜ4, and 50^M 
N a 2 ^ 4  at pH 7.5) and sonicated in ice. Cell lysates mere 
clarified, allquoted and stored at -70°C.
The adenouirus mas gromn in Hela spinner cells and extracted  
using Rrcton as described preuiously (Russel! et al, 1967; 
lUlnters and Russell, 1971).
SPS-PRGE Sodium dodecyisuiphate (SDS)-poiyacrylamide gel 
electrophoresis (PAGE) mas carried out at 150-200^ of 
constant uoltage for 1-1.5 hours on a mini gel system (BIO- 
RAO) or at 70*  ^ ouernlght on a big slab gel (Laemmli, 1970). The 
proteins to be analyzed mere boiled (100oc, 3 min) in gel 
electrophoresis sample buffer (50mM Tris-HCI/2% SOS, 5% 2-  
mercaptoethanol/5% glycerol/0.015% bromophenol blue, at pH
7.0) and loaded (20-50|il) onto a 10% or 16% gel, mhich mas a 
separating gel [10% or 16% of acrylamide : N,N methyiene-  
bisacrylamide ( 50 : 0.235 m /m  ) in 0.37M Tris-HCI/0.1 % 
SOS/0.1% (NH4)2S20e (ammonium persulphate) /0 .12% TEMEO 
( N,N,N',N-Tetramethylethyienediamine ) /  at pH 8.61 ouerlayed 
mith a spacer gel [ 5% of acrylamide : N ,N'methylene-  
bisacrylamide (50 : 1.3 m /m  ) in 0.12M Tris-HCI/0.1 % SOS/0.2% 
TEMEO/0.1% (NH4)2S2Û8 , at pH 6.8]. After electrophoresis, the 
gel mas either blotted to a nitrocellulose f i l te r  paper for  
mestern blotting or stained mith PAGE-blue [ 2% PAGE-blue 
(BOH) in 10% acetic acid/30% methanol 1 and destained in 
acetic acid (10%)-methanol (30%) solution, ssg labelled cell 
extracts mere uisualized by autoradiography of dried gel mith 
Fuji H-ray film.
iOestern blott ing Cell extracts and purified OBP mere  
separated by SDS-PAGE and transferred to a nitrocellulose
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f i l te r  paper at constant currents of 0 .8mfl/cm2 gel for 1 -2  
hours using a semi-drg  e le c tro b lo t te r  (Pharmacia/LKB  
Biotechnology). From the anode (lomer graphite plate of the 
blotter) to the cathode (upper U shape plate of the blotter), 
there mere 6 layers of f i l te r  papers (LUhatman) metted In 
anodic buffer  1 (0.3M Trls-HCI/20% methanol at pH 10.4), 3 
layers of f i l ter papers metted in anodic buffer 2 (25mM Tris- 
HCi/20% methanol at p H I0.4), nitrocellulose f i l te r  paper  
(0 .45j iM , Schleicher&Schull) metted in H2O, SBS-PRGE gel 
mashed once in H2O and 9 layers of f i l te r  papers metted in 
cathodic  b u f f e r  (2 5 m M  T r is -H C I /4 0 m M  6 - a m in o - n -  
hexanoicacid /20%  methanol at pH 9.4). Rfter blotting, the 
nitrocellulose paper mas mashed once in PBS and blocked in 
10%  Maruei/PBS fo r  2 hours or ouernlght at room  
te m p e ra tu re ,  iilashed tmice mith PBS/0.1% NP40, the  
membrane mas incubated mith an antiserum dilution in 5% 
Maruel/PBS for 1-2 hours. Rfter this, the membrane mas 
mashed tmice mith PBS/0.1 % NP40 and incubated mith either  
a secondary antibody labelled mith HRP (horseradish  
peroxidase, Sigma) foilomed by color deueloping mith CNP 
solution ( 15mg 4-chloro-1-naphthol /  5ml methanoi/20m!  
PBS/1 5|il 30% H2O2) or ^25| labelled protein R (Rmersham) 
foilomed by autoradography.
Im m unofluorescence R431 and Heia cells mere gromn on 
multispot miroscope slides in G-MEM/10% NCS in petri dishes 
to 90% confluent. Then, R431 cells mere stimulated or mock- 
stimulated mith 100- 200ng/ml of epidermal gromth factor  
( EGF) to actiuate membrane epidermal gromth factor ( EGFR), 
and Heia cells mere infected or mock-infected mith 20
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p.f.u/cell fld2. After 0.5-1 hours Incubation mith EGF (A431 
celis) and 3-48 hours postinfection (Hela cells) at 37°C (CO2 
incubator), the tmo cells mere mashed tmice in PBS and fixed 
in Formaldehyde (5% Formaldehyde/2% Sucrose/PBS) for 10 
min. The cells mere mashed three times in PBS containing 1% 
nemborn calf serum (NCS) and then penetrated mith NP40 
(0.5% NP40/10% Sucrose/1% NCS/PBS) for 5 min foilomed by 
three times mashing in PBS/1 % NCS. Antisera or ascitic fluid 
mere diluted in PBS/1% NCs in series and spotted onto each 
mell of the slides. After incubation at 37°C in a humidified 
atmosphere for 1 hour, the slides mere mashed in PBS/1 % NCS 
and 1 drop of a 1:100 dilution of FITC (fluorescein  
isothiocyanate) labelled anti-rabbit globulin (Sigma) or Texas 
Red labled anti-mouse globulin (Sigma) mere added to each 
meli. After Incubation (0.5-1 hours, 37°C) and mashing (3-5  
times in PBS/1 % NCS), the slides mere couered and examined 
in a fluorescence microscope. FITC is absorbed at 495nm  
generating an apple-green color and Texas Red is absorbed at 
596nm generating a red color.
Proteolytic digestion of DBP (Cleghon and Klessig, 1992) 5|ig 
of purified Ad2 DBP mas digested mith 0 .03 | ig -2 | ig  of 
chymotrypsin (Sigma) and Trypsin (Sigma) at meight ratios of 
protease : DBP of 1:160, 1:40, 1:10 and 1:2.5. The proteolytic 
digestion reaction mas carried out in 25mM Tris-HCi (pH
8 .0 ) /1m M  EDTA/100mM NaCI in a uoiume of 45|j.l at room 
tem parature for 20 min. After that, 15|ii of 4x SDS PAGE 
sample buf fe r  mas added Into each reaction mix and 
proteolysized DBP fragments mere denatured at 100°C for 3
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min, separated by SDS PAGE, blotted into nitroceliulose f i lter  
paper and probed mith anti-DBP antibodies.
7. Purif icat ion of  antibodies
Purifying polyclonal anti-Ptyr by Bffi-Gel 15 1.5mi of Rffi-gel
(BIO-RRD) mere mashed throughly mith cold deionized H2O and 
mixed mith 3mi of Ptyr (0-phospho-L-tyrosine,  Sigma) 
ouernlght at 4°C on a rocker (Frost et al, 1981). Ptyr mas 
prepared in 50mM Tris-HCI/150mM NaCI pH 7.5 at 25mg/ml.  
150|liI of 1M ethanoiamine-HCi (pH 8.0) mas added to aboue 
coupling mix to block any actlue ester in the gel. Rfter  
incubation at 4°C for a further 1 hour, the gel mas mashed 
mith H2O as before and equilibrated in 50mM Tris/150mM NaCI 
(pH 8.0). 10ml of rabbit antiserum to Ptyr mere mixed mith 
the gel ouernlght at 4°C on a rocker. Rfter mhich the gel mas 
transferred to a 2ml disposable column and mashed mith 40ml 
of 5mM phosphoserine/5mM phosphotheorinine in 5mM  
sodium phosphate pH 7.2 (Kamps and Sefton, 1988). The anti-  
Ptyr antibody mas eluted mith 0.1M Glycine-HCI at pH 2.8 and 
collected in 200|il fractions in Eppendorf tubes containing 20y^ l 
(1 /10  uoiume) of 1M Tris pH 7.5. 5\i\ of each fraction mas 
spotted onto a nitroceliulose paper and the paper mas stained 
mith 1% napthaiene black and destained In 10% acetic 
acid/30% methanol. Peak fractions mere pooled and dialysed 
against PBS.
Purifying monoclonal anti-DBP hy protein G-Seoharose Img  
of protein G-Sepharose 4B fast fiom beads (in suspension in 
20% ethanol, Sigma) mere mashed meli mith PBS and mixed 
mith 2ml of ascitic fluid (clarified prior to mixing) ouernlght at
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4°C mith gentle rocking. Then the gel mas loaded onto a 
column and mashed mith 10-20 bed-uoiumes of PBS and the 
Mflb mas eluted mith 0.1M G!yc!ne-HCI/0.1M NaCI at pH 2.8 in
0.5ml fractions, neutralized mith 50|al (1 /10  uoiume) of 1M 
Tris-HC! pH 7.5. Peak fractions (estimated as aboue) mere 
pooled. Half of It mas dialysed against PBS and half of it mas 
dialysed against coupling buffer (0.1M Borate/0.5M NaCI) for 
making affinity column.
Results:
1. Pre l im inary  tes t  on an t isera
Hn antiserum from the rabbit immunized mith the ptyr-  
KLH conjugate mas double-diluted and applied to an ELISH 
plate mhich had been coated mith ptyr-KLH (immunogen) and 
KLH (the protein carrier) (Fig.1-1. Lanes 3, 4 and 5). To make a 
comparison, the serum mas also neutralized by KLH before  
being diluted out and applied to the plate (Fig.l-1. Lanes 8, 9 
and 10). Figure 1-1 shomed that the serum presented positiue 
in both KLH-coated and (ptyr-KLH)-coated mells before being 
neutralized by KLH but only in (ptyr-KLH)-coated meiis a f ter  
neutra l izat ion  mith KLH, suggesting a specific antibody  
against phosphotyrosine had been raised in the rabbit. Using 
the same conjugate, seueral mice mere immunized and 
similar results mere obtained from these sera by the same 
method of testing (Fig.1-2).
Hnti-sera to Hd2 DBP from the rabbit and mice mere 
tested by ELiSR in a similar procedure (data not prouided). The 
96-meil  plate mas coated mith Hd2 infected and mock-
46
infected Hela cell extracts. To confirm the result, mice anti­
sera mere aiso tested by mestern blotting (Fig.1-3) before a 
fusion mas carried out. From figure i -3 ,  it is suggested that  
the positiue response mhich appeared in the ELISR plate mas 
specific to DBP since corresponding positiue bands appeared 
in mestern biots mere presented in the RdZ infected ceii 
extracts (Fig.i-3. Lanes 2 and 3) but not the mock-infected  
ceil extracts (Fig.i-3. Lane 4).
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F i g . 1 -1 .  Rn ELiSR test for  the specificity of the rabbit 
antiserum to phosphotyrosine. Roms R, B and C, D mere coated 
mith ptyr-KLH; Roms E, F and G, H mere coated mith KLH alone. 
The anti-serum mas applied in double-dilutions as foiioms: B3 
& B8: 1:1000; 84 & B9: 1:2000; B5 & B10: 1:4000; R3 & R8: 
1:8000; R4 & R9: 1:16000; R5 & R10: 1:32000. Similarly, mells 
F3 & F8 to E5 & E l0 mere dilutions of 1:125 to 1:4000. Samples 
in columes 8, 9 and 10 mere neutralized by KLH prior to being 
applied to each meil. Samples in roms C, D and G, H mere 
corresponding dilutions of an antiserum from the rabbit mhich 
had not been immunized by ptyr-KLH.
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F ig J - 2 .  Hn ELISR test of antisera to phosphotyrosine from 
the mice immunized mith the ptyr-KLH conjugate. M: mice BN: 
before neutralization; RN: a f te r  neutralization.
2. Production o f  antibodies
Rnti-Ptyr Mflbs Seueral fusions mere performed using the 
spleens remoued from immunized mice responding positiuely 
to phosphotyrosine on their s e r a . Rbout 2% of the 
supernatants on auerage mere positiue (reacted mith Ptyr-  
KLH) in an ELISR test. From the first tmo fusions, aii positiue
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Fig .1-3. R mestern blot of Rd2 infected and mock-infected  
Heia ceils extracts mith mice anti-sera to DBP. R: a knomn 
anti-serum to DBP from a guinea pig; B and C: anti-sera from 2 
mice immunized mith puified DBP. Lanes 1, 2, and 3; Rd2 
infected Hela cell extracts; Lane 4: Rd2 mock-infected Heia 
cell extracts.
supernatants appeared to react mith KLH (carrier) but not 
mith Ptyr since they presented a positiue result in both Ptyr-  
KLH and KLH coated piates. This probably resulted from 
a poor conjugate ( see discussion ). Rfter modification of 
conjugate preparation by increasing the time allomed for the 
reaction betmeen Ptyr-SPDP and KLH to 1 hour (see 
discussion), further immunization and fusion mere performed 
and specific antibodies against Ptyr mere found in some 
hybridoma celis. Thus subcioning rescreening and 
resubcioning mere carried out, and finaliy three MRbs mere 
isoiated and haruested as ascitic fiuid. Surprisingiy, mhen 
these three MRbs had been characterized they mere found 
to be MRbs to BSR but not to Ptyr. BSR mas used as a carrier 
protein of Ptyr in aii screening assay (i.e. ELISR plate mas 
coated mith Ptyr-BSR). in a phosphatase actiuity test  
(standard p-nitrophenol phosphate assay, Sigma), both BSR 
and KLH appeared to be positiue and BSR mas stronger
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(data not prouided). This suggests that the phosphate in the 
phosphotyrosine linked to BSR had been taken off  gradualiy 
by a trace of phosphatase in the carrier protein during the 
long process, leading to a selection of MRbs to BSR (see 
discussion).
Rnti-DBP MRb T lu o  fusions haue been performed for anti-DBP 
MRbs. Rbout 4% of the supernatants mere presented positiue 
In the first screening. Only 20-30% of the positiue hybridoms 
remained positiue in the second screening (i.e. a f te r  first  
subcloning). For the f i rs t  fusion, an t i -DBP-secre t ing  
hybridoma cells died gradually during the first and second 
subcloning. For the second fusion, homeuer, tmo anti-DBP- 
secreting hybridomas 12B8 and 15C2 mere isoiated and anti-  
DBP MRbs mere haruested as ascitic fiuid. The ascitic fiuid of 
15C2 appeared not to react mith DBP since in an ELISR test, 
the ascitic fluid from 12B8 has a high t i tre in reacting mith 
DBP mhile the ascitic fluid from 15C2 has a negatiue response 
to DBP.
3. C h arac ter iza t ion  of antibodies by immunoassay  
Polyclonal anti-Ptyr recognizes EGFR in R431 ceil membranec 
R431 Is a human epidermoid carcinoma cell line mhich has 
been identified to haue an unusually high number of specific 
epidermal gromth factor receptors (EGFR) in Its membrane 
(LDrann and For, 1979). The EGFR has a tyrosine kinase actiuity 
and is autophosphorylated mhen stimulated mith epidermal 
gromth factor (EGF) at physiological concentrations (Hunter 
and Cooper, 1981). Thus R431 cells mere used in antibody 
identification as a positiue control substrate for  tyrosine
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kinase and In inuestlgating tyrosine phosphorylation on DBP 
as both a substrate and a kinase (see part II).
In a immunofluorescence assay, R431 cells mere gromn 
on slides to 90% confluent, stimulated and mock-stimulated  
mith lOQng/mi of EGF, and probed mith a 1 : 200 dilution of 
rabbit antiserum against Ptyr. Commercial ant i -Ptyr MRb PT- 
66 (Sigma) mas used (1:100) as a positiue control. R rabbit 
antiserum to DBP and an unrelated ascitic fluid Bio/4 mere 
used as negatiue controls. Rfter Immunostaln mith FITC or 
Texas Red linked secondary antibody, bright fluorescence 
appeared only in EGF stimulated R431 cell membrane that had 
been probed mith polyclonal an t i -P ty r  (Fig.1-4. fl.) and 
monoclonal anti-Ptyr antibodies (data not shomn), suggesting 
that  the rabbit polyclonal a n t i -P ty r  serum specifically 
recognizes natiue phospho tyro sine-containing protein as 
commercial MRb to Ptyr does. Hs a comparison, Figure 1-4 
shoms the result of EGF stimulated and unstimulated R431 
cells probed mith the rabbit antiserum to Ptyr. From Fig. R and 
B, It can be seen clearly that there is an significant Increase in 
the phosphotyrosine leuei in membranes betmeen stimulated 
and unstimulated cells.
For a mestern blotting assay, R431 celis mere gromn in 
8cm dishes, stimulated mith EGF in uiuo and in uitro (see part 
I I  methods), separa ted  by SDS PAGE, t ra n s fe r re d  to 
nitrocellulose f i l t e r  paper and probed mith the same 
antibodies as used in an immunofluorescence assay described 
aboue. Specific bands appeared in the blots that mere probed 
mith anti-Ptyr rabbit serum (Fig.l-5. fl) and Mflb PT-66 (Fig.i-
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Fig.1-4. Immunofluorescence assay on H451 cells stimulated 
mith EGF (fl) or without EGF (B) foilomed by probing mith the 
rabbit anti-Ptyr antibody.
5. C), suggesting that an t i -P tyr  rabbit serum recognized a 
denatured phosphotyrosine-containing protein. To in uitro EGF 
stimulated B451 cell membrane extracts, anti-Ptyr rabbit 
serum and Mflb PT-66 reacted in the same may (Fig.l-5. Lanes
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F i g . l - 5 .  LUestern blotting on EGF stimulated and mock-  
stimulated R431 cell membrane extracts  probed mith  
antibodies against Ptyr. Lanes 1 (and 2): EGF in uitro  
stimulated (and m ock-st im ulated)  R431 cell membrane  
extracts; Lanes 3 (and 4): EGF in uiuo stimulated (and mock- 
stimuiated) R431 cell membrane extracts. A. anti -Ptyr rabbit 
serum (1:250); B. control rabbit serum (anti-DBP, 1:250); C. 
an t i -P tyr  MRb PT-66 (1:100); D. control mouse ascitic fluid 
Bio/4 (1:100).
1 and 2 in A. C.). To in uiuo EGF stimulated ceil membrane 
extracts, MRb PT-66 also recognized EGF mock-stimuiated  
EGFR (containing lomer ieuer of phosphotyrosine) but anti-  
Ptyr rabbit serum did not (Fig.l-5. Lanes 4 in R. C.); mhereas 
anti -Ptyr rabbit serum picked up an extra phosphotyrosine-
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containing protein mith lomer molecuiar meight in both EGF 
stimulated and unstimulated cell membrane extracts but MRb 
PT-66 did not (Fig.l-5. Lanes 3 and 4 in R. C.), suggesting that 
although an t i -P tyr  rabbit serum can recognize denatured  
phosphotyrosing-containing protein as PT-66 does, it behaues 
differently from PT-66.
MRb 12B8 recognizes natiue and denatured forms of both 
uirai DBP and expressed DBP
To test m hether anti-DBP MRb ( I2B 8)  recognizes  
denatured DBP and DBP expressed in Bacuiouirus. Rd2 infected 
and uninfected Hela ceil extracts, purified uirai DBP (U-DBP) 
and purified Bacuiouirus DBP (B-DBP) mere absorbed to a 96-  
mell ELISR plate and an ELISR mas performed. The same 
protein samples mere also run on a SDS gel and transferred to 
a membrane mhich mas then probed mith different MRbs. Tmo 
knomn anti-DBP MRbs B6 and R1 (Reich et al, 1983) mere used 
fo r  comparison. 86 recognized both natiue and denatured  
forms of DBP mhereas R1 only recognized the natiue form of 
DBP. RH MRbs mere used at a 1:500 dilution in mestern  
blotting. In ELISR MRbs mere applied in a dilution series 
(starting at 1:100) but only OD readings from a 1:500 dilution 
(same as used in mestern blotting) of each MRb at 492nm 
mere selected and presented mith corresponding blots (Fig.l- 
6). From figure 1-6, it can be seen that anti-DBP 12B8 
specificaiiy recognized DBP in crude ceii extracts (Fig.i-6. R. 
Lanes 1 and 2), purified form of mild type uirus (Fig.1-6. R. 
Lane 3) and recombinant bacuiouirus (Fig.i-6. R. Lane 4).
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Fig.1-6. ELISH and LUestern blotting on MRbs to Rd2 DBP. R. 
12B8; B. 86; C. R1. Lane 1 : uninfected Hela cell extracts; Lane 
2: Rd2 infected Hela cell extracts Lane3: B-DBP Lane 4: U-DBP
MRb 12B8 is not a protein R binder To determine mhether  
MRb 12B8 is a protein R binder or not, 2 membranes (blotted 
mith DBP) mere probed mith 12B8. Then one of them mas 
incubated mith labelled protein R foilomed by
autoradiography and the other mas incubated mith an anti-
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BF ig . l -7 .  Rn autoradiography of mestern blots probed mith 
MRb 12B8 foilomed by: R. incubating directly mith ^Z5| 
labelled protein R; B. mith rabbit anti-mouse IgG prior to the 
addition of labeiled protein R. C. negatiue control: same 
as B. but the membrane mas probed to a negatiue control 
ascitic fiuid Bio/4.
mouse rabbit immunoglobulin before addition of labelled 
protein R. Rfter autoradiography DBP bands appeared in the 
membrane incubated mith rabbit antiserum to mouse 
immunogiobulin prior to the addition of protein R (Fig.l-7. B), 
but not in the membrane incubated mith protein R directly 
(F ig .l -7 .  R), suggesting that anti-DBP MRb 12B8 is not a 
protein R binder.
MRb binding to orotease-diqested DBP fragment To identify 
mhich proteolytic fragment of DBP reacts mith MRb, purified 
DBP mas digested mith chymotrypsin and trypsin, separated 
by SDS PRGE, blotted to nitroceliulose f i lter paper and probed 
mith both MRb and PRb (polyclonal antibody) to DBP. 
Surprisingiy, a f te r  intensiue treatment mith proteases, there 
mas no significant difference in Rg (antigen)-Rb (antibody) 
interaction pattern betmeen MRb and PRb in mestern blotting 
(Fig.1-8). This suggests that DBP may contain only a fem linear
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Fig.1-8. LUestern blotting of proteolytic digests of purified 
DBP (5/ig). Lane 1; untreated  purified DBP; Lanes 2-5:  
chymotrypsin treated DBP (O.03p.g, 0.125|ig, 0.5|ig and 2|xg 
protase per digestion respectiuely); Lanes 6-9:  trypsin  
treated DBP (0.03^g, 0.125^g, 0.5^g and 2^g respectiuely). R. 
The blot uias probed mith MRb 12B8; B. The blot mas probed 
mith rabbit PRb
antigenic sites and the MRb 12B8 probably recognized the 
major linear antigenic site of the protein. By chymotrypsin 
digestion, one major band appeared in both blots (Fig.1-8, R 
and B, Lanes 4 & 5) Just beiom the molecular meight marker  
of 44 .6K (Fig.i-8). By trypsin digestion, it can be seen more 
clearly that almost only one band appeared in blots (Fig.i-8, R 
and B, Lanes 8 & 9) and it has an apparent molecular meight
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of about 39K (Fig.1-8). Do these results suggest that the 
antigenic site recognized by the MRb 1288 is located at the C- 
terminal of the protein? I f  this is true, the MRb mould be uery 
useful in isolating DNR binding sites of the DBP in this domain. 
To confirm this, further experiments are required.
4 .  Purif icat ion of antibodies
Rabbit antiserum to Ptyr mas purified using an Rffi-Gel 
15 column mhich had been coupled mith Ptyr (see methods). 
Peak fractions eluted from the column mere pooled and 
tested for its purity and function. By dot blotting, the 
antiserum ioad , flom-through and elute mere double-diluted 
(starting at 1:10) and spotted (3jil) to a membrane, mhich had 
been coated mith Ptyr-KLH, and incubated mith labelled 
p ro te in  A fo r  15 min fo i lom ed  by mashing and 
autoradiography (Fig.1-9). Here, antiserum "load" stands for  
the fraction of the antiserum that has not been applied to the 
column [i.e. anti-(Ptyr-KLH)]; "fiom-through" stands for the 
fraction of the antiserum that had been applied to the column 
and passed through the column (i.e. anti-KLH portion of the 
antiserum); and "elute" stands for  the fraction of the 
antiserum that had been applied to the column, bound to the 
column and eluted from the column by lorn pH buffer (i.e. anti-  
Ptyr portion of the antiserum). From figure 1-9, it shoms that 
the m a jo r i ty  of antibodies in the antiserum (before  
purif ication) mere anti-KLH (F ig . i -9 .  rom B), a n t i -P ty r  
antibody mas only a small portion (Fig.1-9. rom C). LUhether 
this small portion of anti-Ptyr antibody had been fully
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F lg . l -9 .  Rn autoradiograph of a Dot blot. The conjugate of 
Ptyr-KLH uias absorbed to a nitrocellulose f i l te r  paper on 
mhich rom R mas spotted mith antiserum ioad [an t i - (P tyr-  
KLH)], rom B mas spotted mith antiserum flom through (anti-  
KLH) and rom C mas spotted mith antiserum elute (anti-Ptyr).  
Lanes 1-8 mere doubling-diiutions of each antiserum from 
1:10 (Lane 1) to 1:1280 (Lane 8).
separated from the majority anti-KLH antibody or not, these 
antiserum fractions (ioad, f iom-through and elute) mere  
fu r ther  examined by an immunoprécipitation assay using 
phosphotyrosine-containing R431 ceil extracts, since the 
phosphotyrosine-containing protein used in Dot blotting mas 
the immunogen of phosphotyrosine linked KLH (Ptyr-KLH).
For Immunoprécipitation, R431 cell membrane extracts  
and solubilized extracts mere stimulated mith EGF, labeled 
mith 32p and immunoprecipitated (see part ii methods) mith 
the antiserum ioad lanti-(Ptyr-KLH)], fiom-through (anti-KLH) 
and eiute (anti-Ptyr).  The result presented in F ig . i -10 shoms 
that tyrosine-phosphoryiated EGFR (in R431 cell extracts) mas 
immunoprecipitated by antiserum load and eluate (Fig.1-10. 
Lanes 1, 3, 4, 8, 10 and 11) but not by fiom-through (Fig.l-10.
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F ig .1-10.  Rn autoradiography of EGF stimulated R431 cell 
extracts Immunoprecipltaed mith antiserum fractions (ioad, 
fiom- through and elute) a fte r  the extracts haue been labeled 
mith 52p in uitro. Lanes 1-7 mere soiubiiized extracts and 
lanes 8 -1 4  mere membrane extracts .  Lanes 1 and 8: 
antiserum load [anti-(Ptyr-KLH)]; Lanes 2 and 9: antiserum 
flom-through (anti-KLH); Lanes 3&4 and 10011: antiserum  
eiuate (anti-Ptyr); Lanes 5012: control rabbit antiserum (anti-  
SU5); Lanes 6013: commercial an t i -P tyr  MRb PT-66; Lanes 
7014: control ascitic fluid of Bio/4.
Lanes 2 and 9), suggesting that antiserum that has been 
applied to and passed through the column does not contain 
any a n t i -P ty r  antibody. R n t i -P ty r  antibody has been 
completely separated from anti-KLH antibody in the rabbit 
serum and purified anti-Ptyr antibody functioned as before in
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immunoprécipitation since it had been denatured during 
purification.
To check the purity and to estimate the concentration of 
the purified antibodies, purified anti-Ptyr polyclonal antibody 
and anti-DBP Mflb mere analysed by SDS PRGE, using different  
concentrations of BSR as standards (F ig .i -11). Figure 1-11 
shoms that only one heauy chain and one light chain appeared 
in both antibodies (F ig . l -11. Lanes 4, 6 and 7), suggesting the 
tmo antibody products are pure, and the es t im ated  
concentration of ant i -Ptyr  antibody is 2mg/ml and anti-DBP 
antibody is Im g/m l (F ig .l -11).
F ig . l - 1  1. SDS PRGE of purified antibodies. M: molecuiar  
meight marker: 205K, 116K, 97K, 66K, 45K and 29K. Lanes 1 -3: 
BSR of 2mg/ml, Im g /m l  and 0.5mg/ml respectiuely; Lane 4: 
purified ant i -Ptyr polyclonal antibody; Lane 5: Ptyr-column 
mash; Lane 6 and 7: purified anti-DBP MRb in PBS and coupling 
buffer respectiuely; Lane 8: protein G column mash.
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Discussion:
1. Failure to make a n t i -P ty r  MRb
Phosphotyrosine-containing proteins can be detected by 
au to rad iog ra ph y  of gels t re a te d  mith a lka i i  since 
p h o spho tyros ine  is more a ik a i in e  re s is ta n t  than  
phosphoserine and phosphothreonine (Cooper et ai, 1983). But 
it is not an ideai method to examine phosphotyrosine in 
proteins not only because of its high background and lom 
sensitiuity. Most importantly, not all of the phosphoserines 
and phosphothreonines are hydrolyzed during aikaiine  
treament (Yin and ILlang, 1988). LUe found it uery difficult to 
achieue satisfactory results detecting phosphotyrosine by 
aikaiine treatment. Ross et al first deueioped antibodies for  
phosphotyrosine using p-azobenzyi phosphonate (RBP) (Ross 
et ai, 1981). This approach nom has been meil extended and 
used in studying protein tyrosyl-phosphoryiation. RIthough 
commercial antibodies against phosphotyrosine are auailable 
the extremely high price make It Impossible to use it In 
multiple experiments. Therefore, it mas decided to make our 
omn anti-phospho tyro si ne antibodies to study the OBP 
tyrosyl-phosphoryiation. Because phosphotyrosine is too 
small to induce an immune response, uarlous methods haue 
been used to couple phosphotyrosine (or its analogs) to a 
protein carrier to generate effectiue immunogens. LUe used 
the heterob ifun ct iona l  reag en t  N-succinimicyl 3 (2 -  
pyridyldithlo) propionate (SPBP) as a linker, and Keyhole 
limpet hemocyanin (KLH) as a protein carrier to prepare the 
conjugates of Ptyr-KLH and Ptyr-BSR according to the method
62
of Carlsson et al (Carlsson et al, 1978). The prepared  
conjugate of Ptyr-KLH has been used to immunize a rabbit 
and mice and generated antibodies against phosphotyrosine 
(Fig.1-1, 1-2). The prepared conjugate of Ptyr-BSf) has been 
used in a screening assay of ELfSR as a coating antigen. The 
quality of the conjugates and the method used in the 
screening assay directly affected the production of Mflb. 
Generation of a poor con iugate N-succin im idyt  3 - ( 2 -  
pyridyldithio) propionate (SPDP) is a heterobifunctional  
reagent. It  contains one N-hydrongsuccinimide ester moiety 
and one 2-pyridyl disulphide moiety. The hydroxysuccinimide 
ester reacts luith the amino group of Ptyr firstly to giue a 
stable amide bond, and the 2-pyridlyl disulphide group reacts 
ujith aliphatic thiols of KLH or BSR aftermards. In aqueous 
form, the N-hydoxysuccinimide ester of SPDP is decreased 
quickly because of hydrolysis. In ethanol it is stable (Carlsson 
et at, 1978). I f  there are amino groups in the media, the 
aminolysis of N-hydroxysuccinimide ester is much faster than 
the hydrolysis (Fig.1-12). In the first step of coupling, Ptyr-  
SPOP Luas formed by aminolysis of N-hydroxysuccinimide 
ester of SPDP mith amino group of Ptyr, so it is important to 
prepare the SPDP solution in ethanol and dilute it ( If
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Fig.1-12. SPDP aminolysis and hydrolysis by measuring the 
absorbance of the N-hydronysuccinimide released from both 
aminolysis and hydrolysis of SPDP at A,maH = 2 6 0 n m .  
Methodology uias as described in the Pierce handbook, 
spectrophotometry mas carried out using a Perkin Elmer 
lambda 5. The aminolysis of SPDP takes about 20 min 
uihereas the hydrolysis of SPDP takes about 40 min.
necessary) Just before use or directly into the reaction  
mixture to auoid the hydrolysis of hydroxysucclnimide ester  
before it reacts mith Ptyr. It is also important to control the 
molar ratio of Ptyr/SPDP to be 1 or greater than 1 to auoid the 
excess of SPDP (SPDP and Ptyr contain one hydroxysuccinimide 
ester  and one amino group respectiuely),  since the N- 
hydroxysuccinimide ester of excess SPDP mould be hydrolyzed 
mhereas the 2-pyridyl disulphide moiety of excess SPDP 
mould take part in the next reaction to generate a conjugate 
of linker and carrier. Such a conjugate mould only generate  
anti-KLH (carrier) antibody.
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In the second step of coupling, the extent of thlol-  
dlsulphide exchange of the 2-pgrldgl disulphide group In SPDP 
and the aliphatic thiols in BSR (or KLH) depends on the amount 
of Ptgr-SPDP and BSR (or KLH) to be used (Fig.1-13). It  Is 
expected that  the protein carr ie r  molecule could be 
surrounded by as many Ptyr molecules as possible (i.e. a high 
degree of substitution). Thus an excess of Ptgr-SPDP is 
required. In contrast, an excess of the protein carrier Is 
auoided. It  mould result In a poor conjugate (mith Io u j  degree 
of substitution) and generate an antibodg to carrier. It can be 
seen that uihen the content of Ptgr-SPDP is greater  than 
0.5mM, the product of Ptgr-BSR does not increase mith Ptgr- 
SPDP (Fig.1-13. R); it increases linearly uilth BSR (Fig.1-13. B). 
This suggests that the 2-pgridyl disulphide groups haue been 
saturated. UJhen the concentration of Ptgr-SPDP is in the 
range of 0.5mM-4mM, the concentration of BSR could change 
from 0.1 mM (6.8mg) to 0.8mM (54.4mg) and the relationship 
betmeen Ptgr-BSR and BSR remains linear (Fig.1-13. fl). Thus In 
FIG.1-13.
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F ï g . I - 1 3 .  Thiol-dïsulphide exchange of the 2-pyr id ly l  
disulphide group in SPDP and the aliphatic thiols in BSR 
determined by measuring the absorbance of the pyridine-2-  
thione released from the thiol-disulphide exchange reaction 
at ^max=343nm. R) Rbsorbance of Ptgr-BSR as a function of  
Ptgr-SPDP; B) Rbsorbance of Ptgr-BSR as a function of BSR.
the case of 5mM Ptgr-SPDP and 10mg BSR (or KLH) mhich mere 
used in coupling reaction, there are plenty of 2-pyridyl  
disulphide groups to be used in exchange reaction. H poor 
conjugate is unlikeig to be generated by an excess of the 
protein.
It should be pointed out that the time of thiol-disulphide 
exchange reaction uaries from 10 min to 3.5 hours depending 
on the amount of protein being used (Fig.1-14. R). Dbuiously, if 
the reaction is stopped by dialysis process, a poorer  
conjugate (lomer degree of substitution) is thus generated. It 
takes about 1 hour to finish the reaction of thiol-disulphide 
exchange for BSR at 0.2mM (13.6mg) (Fig.1-14. B). Dniy 40 min
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Luas used in thiol-disulphide exchange reaction in preparing 
the conjugate mhich had been used in immunizing the mice 
for the first 2 fusions.
Selection of antibody-secreting hybridomas In the screening 
assag of ELISA, Ptyr-KLH and KLH mere first used as coating 
antigens and MRbs mere selected indlrectig bg reacting mith 
Ptgr-KLH conjugates (immunogen) and KLH (protein carrier). 
Only the one mhich has a positiue reaction mith Ptyr-KLH and 
a negatiue reaction mith KLH mould be selected. This method 
doubled labour and did not prouide clear results. Thus BSR, an 
unrelated protein, mas used in coupling of Ptyr to form a 
conjugate of Ptgr-BSR, and the Ptgr-BSR conjugate mas then 
used as a coating antigen in ELISR in place of Ptyr-KLH & KLH 
throughout the process. In a phosphatase actiuity assay, both 
KLH and BSR appeared positiue, suggesting that  they  
contained phosphatase ( euen a trace amount, phosphatase 
contamination mould be a disaster in this application). Ptyr-  
KLH and Ptgr-BSR mere prepared at the same time and stored 
in 4°C. For immunization of the mice, Ptyr-KLH mas used in 
the first 6-7 meeks after  preparation mhile for the screening 
of hybridoma cells, Ptgr-BSR mas used tmo months later after  
preparat ion.  During this period, probabig, a trace of 
phosphatase acted slomlg on the phosphate and gradually 
dephosphorylated the conjugate, resulting in the generation 
of ant i -Ptgr  antibodg in mice sera homeuer the screening 
procedure mould select anti-BSR antibodies.
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2. Mflb binding and DNR binding of DBF
To determine mhich part of DBP mas recognized by Mflb 
12B8, purified uiral early DBP (uiral ONfl replication mas 
blocked by hydroxyurea during Infection), late DBP (uiral DNfl 
replication mas not blocked during infection) and baculo-uiral 
DBP mere digested mith different amount of chymotrypsin 
and trypsin. The proteoiysed DBP fragments mere analysed by 
mestern blotting mith rabbit polyclonal antibody (Pflb) and 
Mflb to DBP. No difference mas found in fly (antigen)-flb  
(antibody) interaction pattern in mestern blotting betmeen  
Pflb & Mflb (Fig.1-8), early DBP & late DBP (data not shomn) 
and uiral DBP & baculo-uiral DBP (data not shomn). Probably 
these three species of DBP contain the same proteolytic  
cleauage sites in a purified form and present a m a jor  
antigenic site in a denatured form. DBP may contain only a 
fem l inear antigenic epitopes and the m a jo r  one mas 
recognized by Mflb 12B8 since Pflb apparently did not detect 
more fragments of digested protein as one mould expect. It is 
possible (not necessary) that this major linear epitope may be 
located at C-terminal since a f te r  Intensiue treatm ent mith 
proteases (the meight ratio of DBP to protease mas up to 
2.5:1), one major band appeared in mestern blotting mith an 
apparent size of about 39K (Fig.1-8, Lanes 3 & 4, 7 & 8) and 
this has been shomn by preuious results to be deriued from C- 
terminal.
It  is of interest to knom mhether binding of DBP to this 
Mflb (12B8) affects the ability of DBP to bind to DNfl and uice 
uersa. Thus, Mflb binding and DNfl binding experiments mere 
carried out and performed first employing a dot blotting
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assay and then using a gei retardation assay. In a dot blotting 
assay, DBP mas absorbed to a nitrocellulose f i l te r  paper and 
the paper mas blocked mith 10% Maruel/PBS follomed by 
incubation mith (1) 32p-.fabelled ssDNR (control) (2) Mflb then 
radioactiue ssDNfl (3) labelled ssDNfl then Mflb. DNfl binding 
can be Identified by autoradiography and Mflb binding can be 
identified by immunostaining mith peroxidase linked anti­
mouse IgG. Surprisingly, no radioactiuity mas detected in any 
of the blots, suggesting that DNfl did not bind to DBP under 
these conditions. LUhen DNfl mas absorbed to nitrocellulose 
f i l ter  paper and the paper mas blocked mith Maruei and then 
incubated mith DBP follomed by an antibody to DBP, a positiue 
result mas obtained (data not shomn), indicating that DBP had 
bound to DNfl. Probably mhen DBP attached to the f i lter paper, 
the auailability of its conformation mas reduced. For Mflb 
binding. It may require mainly an exposed antigenic epitope 
mhile for DNfl binding, it requires not only the primary  
structure but also the enuironmental conformation and 
possibly the inducibility of the conformation change of the 
protein to maintain the binding. Compared mith aqueous 
media, mhen DBP mas absorbed to a solid m atr ix  
(nitrocellulose f i l te r  paper), its inducibility In conformation 
change mas reduced and this probably limited its ability to 
bind to DNfl. In a gel retardation assay (Fig.1-15, Part II 
Methods 7), 0.5jig of purified DBP mas either incubated (0°C, 
30 min) mith Mflbs 12B8 (purified form at 1 mg/ml. Lanes 3-6  
corresponding to dilutions of 1:8, 1:4, 1:2 & 1:1 respectiuely) 
and fli (ascitic fluid, Lanes 7-9  corresponding to dilutions of 
1:8, 1:4 D 1:2 respectiuely) prior to reaction (0°C, 15 min) mith
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ssDNH 32p labelled 18bp oligonucleo t ide at 100
counts/jLil/min) or incubated (0°C, 15 min) mith ssDNfl prior to 
reaction (0OC, 30 min) mith Mflbs 1288 (Lanes 10-13) and fli 
(Lanes 14-16). From figure 1-15, it Is Interesting to see: (1 ). 
LUhen DBP mas incubated mith ssDNfl only, there mere tmo 
bands of DBP-DNfl complex mith different mobilities (Lane 2), 
(2). LUhen DBP mas Incubated mith Mflb 12B8, mhich 
recognizes a linear epitope of DBP (see this part, results 3), 
prior to reaction mith DNfl, the top band mas further retarded 
as the amount of 12B8 increased mhile the bottom band 
remained the same (Lanes 3-6).  LUhen DBP mas incubated mith 
DNfl prior to reaction mith 12B8, the same result (interaction 
pattern) mas obtained (Lanes 10-13).  (3). LUhen DBP mas 
incubated mith Mflb HI, mhich recognizes a conformational (or 
discontinuous) epitope of DBP (fleich et al, 1983), prior to 
reaction mith DNfl, both the top and bottom bands mere  
retarded further as the amount of fli increased (Lanes 7-9).  
LUhen DBP mas incubated mith DNfl prior to reaction mith fli,  
the top band mas fu rther  redarded and the bottom band 
remained the same (Lanes 14-16). To confirm these results, 
the same experiment mais repeated using a reduced amount 
of DBP (D.ljag instead of 0.5|ig) and increased amounts of Mflb 
(12.5 fold excess instead of 5 fold) and ssDNfl probe (1.5p.l 
instead of 1|il), and the same results mere obtained (Fig.1-16). 
LUhen DBP reacted mith ssDNfl at lom concentrations  
(<0.1|ig/20|il reaction uolume), probably it inuolued mainly a 
protein-DNfl interaction and DBP may bind to DNfl as 
monomers, resulting In one retarded band in the gel mith 
higher mobility (Fig.1-16, Lane3). LUhen the amount of DBP
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Fig.1-15. Gel retardation assay of MHb binding & DNR binding 
of DBP. Lanel: ssDNH LaneZ: DBP (0.5|ig)/ssDNR (control); 
Lanes3-6: DBP/12B8 (1:8, 1:4, 1:2 & 1:1)/ssDNA; Lanes7-9: 
DBP/fll (1:8, 1:4 0  1:2)/ssDNfl; Lanes10-13: DBP/ssDNR/1288 
(1:8, 1:4, 1:2 O 1:1); Lanes14-16: DBP/ssDNfl/R1 (1:8, 1:4 D 1:2). 
The molar ratio of DBP:MRb used here mas 1:1.25, 1:2.5, 1:5 
and 1:10 corresponding to dilutions of MRb of 1:8, 1:4, 1:2 and 
1:1 for 1288.
increased in the same reaction uolume, apart from the 
protein-DNfl interaction, protein-protein  interaction may 
occur and DBP may oligomerize and bind to DNfl as oligomers
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e.g. dimers, resulting in tmo retarded bands in the gel mith 
different mobilities (Fig.1-16, Lanes 2 & 1; Fig.1-15, Lane2). 
LUhen MRb bound to DBP, it did not affect the auailability of 
DBP for DNR binding since there mas a shift upon binding of 
DNfl to the DBP-Mflb complex (Fig.1-15, Lanes 3-9; Fig.1-16, 
Lanes 4 & 5 and 8 & 9), but the binding of DBP to DNfl affected  
the binding of DBP to Mflbs (Fig.1-15, Lanes 10-16; Fig.1-16, 6 
O 7 and 10 11) and the stability of the DBP-Mflb complex
1 2 3 4 5 6 7 8 9 1 0 1 1 1 2
W W W W  W w
Fig.1-16. Gel retardation assay of Mflb binding O DNfl binding 
of DBP. Lanel : 0.5|ig DBP/ssDNfl (1.5|il); Lane2: 0.2^g 
DBP/ssDNfl; Lane3: 0.1|ig DBP/ssDNfl (control); Lanes 4 & 5: 
DBP/12B8 (1:4 & 1:1)/ssDNfl; Lanes 6 0  7: DBP/ssDNfl/12B8 (1:4 
O 1:1); Lanes 8 0  9: DBP/fll (1:4 O l:1)/ssDNfl; Lanes 10 0  11: 
DBP/ssDNfl/fll (1:4 O 1:1); Lanel2: ssDNfl/12B8 (1:1) + fli (1:1). 
The molar ratio of DBP:Mflb used here mas 1:6.25 and 1:25 
corresponding to dilutions of Mflb of 1:4 and 1:1 for 12B8.
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(Fig.1-15, Lanes 3-6; Fig.1-16, Lanes 4 O 5). Binding of DBP to 
DNR apparently induces a conformational change in DBP as 
luell as DNfl and this change probably in turn stabilizes the 
DBP-DNfl complex. UJhen DBP mas incubated mith DNfl prior to 
the addition of Mflb, the conformation change induced In the 
protein upon binding of DNfl may a l te r  its discontinuous 
epitopes or shelter its linear epitopes, resulting in the failure 
of these epitopes to be recognized by Mflbs such as 12B8 and 
fli (lomer shifted bands of Fig.1-15, Lanes 10-16; Fig.1-16, 
Lanes 6 D 7 and 10 & 11). In the case of oligomers of DBP 
(mhen protein-protein interaction mas inuolued), some DBP 
molecules may be not in direct contact mith DNfl or their  
conformation had not been changed much, retaining the 
auailability of the epitopes for Mflb binding (higher shifted 
bands of Fig.1-15, Lanes 10-16; Fig.1-16, Lanes 6 & 7 and 10 
11). In the case of DBP-Mflb complex, mhen Mflb binding did 
not affect DNfl binding e.g. DBP-12B8 and DBP-fll, the induced 
conformational change in DBP upon binding to DNfl may result 
in a disassociation of DBP from Mflb (lomer shifted bands of  
Fig.1-15, Lanes 3-6; Fig.1-1 6, Lanes 4 & 5).
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Part II Tyrosine phosphorylation of DBF
Before a n t i -P ty r  antibodies had been established,  
phosphotyrosine-containiny protein mas detected by alkali 
treatment of 32p labeled samples separated in a SOS gel prior 
to autoradiography (Cooper et al, 1983), or by base hydrolysis 
of the samples follomed by phosphoamino acid analysis 
(Martensen and Leuine, 1983), The former technique assumed 
that the phosphate ester linkage to tyrosine is stable to high 
pH. Homeuer not all phosphotyrosyl residues are resistant to 
high pH and phosphothreonine in some situations Is also 
stable to high pH. Nom anti -Ptyr antibodies are most midely 
used in detecting phosphotyrosine-containing proteins in 
immunoassay (Yin and lllang, 1988) such as mestern blotting 
and i m m u n o p r é c i p i t a t i o n .  P r o te in s  c o n ta in in g  
phosphotyrosine thus identified can then be purified by 
immunoaffinity chromatography (Pang et al, 1985).
Using synthetic peptides, the actiuity of protein tyrosine 
kinases can be measured by incubating the protein mith the 
peptide in the presence of (y-32p)pTp (radioactiue assay) or 
RTP (nonradioactiue assay). Tyrosyl-phosphorylated peptide 
can then be counted fo r  ^^P-labeling by adherence to 
phosphocellulose paper or identified by an t i -p ty r  antibodies 
in the case of nonradioactiue labeling.
Peptide RR-SRC (Bomen et al, 1991) and poly (Glu.Na, Tyr) 
4:1 (Rijksen et al, 1989; Lazaro et al, 1991) are artificial  
substrates used in tyrosine kinase assay. RR-SRC is designed 
for a f i l ter  assay mith tmo arginines attached to the amino
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terminus. Poly (Glu.Na, Tyr) 4:1 can be finked to a ELISR plate, 
facilitating a nonradioactiue assay for tyrosine kinase.
Methods:
1. P repara t ion  o f  R43I  cell e x t ra c ts  containing EGFR 
(Varden and Schlessinger, 1987)
Membrane extracts R431 human epidermoid carcinoma cells 
mere gromn in G-MEM/10% NCS in 8cm dishes to confluency, 
mashed tmice mith PBS, scraped off  and pelleted in PBS at 
600g for 10 min (4°C, benchcentrifuge). The cell pellet mas 
resuspended In 10 uolumes of hypotonic buffer (10mM Hepes, 
1.5mM MgClz, Im M  PMSF and Im M  EGTR at pH 7.4) and 
incubated at 4°C fo r  10 min. The lysate mas briefly  
homogenized by 3-5 strokes mith a glass dounce homogenizer 
and centrifuged (600g, 10 min, 40C). The pellet mas discarded 
and the supernatant mas further centrifuged at 24,000g for 
30 min at 4°C. The resulting pellet mas then resuspended in 20 
uolumes of HNEG buffer (20mM Hepes, 150mM NaCI, Im M  EGTR 
and 10% Glycerol at pH 7.4), homogenized (10 strokes) and 
loaded on 35% sucrose/PBS. Rfter centrifugation at 24,000g 
for 30 min at 4°C, the interface fraction mas collected, diluted 
1:5 in 10mM Hepes (pH 7.4) and recentrifuged at 100,000g for  
20 min at 4°C. The resulting pellet mas resuspended in 20mM  
Hepes pH 7.4, aliquoted and stored at -70°C.
Solubilized extracts Confluent R431 cells mere mashed tmice 
mith HNEG (20mM Hepes/150mM NaCI/ImM EGTR/10% Glycerol, 
pH 7.4) and pelleted in HNEG. The cell pellet mas stored at 
-70»C until use. The frozen cells mere suspended in 1ml of
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solubilization buffer (50mM Hepes, 150mM NaCI, 1 % Triton H- 
100, 10% Glycerol, 1.5mM MgClz, Im M  EGTH and Im M  PMSF 
containing 0.15 trypsin Inhibitor unit /ml of aprotinin and 
10jig/mi of leupeptin at pH 7.5), homogenized (14 strokes) and 
clarified at 40,000g for 30 min at 4°C. The supernatant mas 
aliquoted and stored at -70°C.
2. EOF st imulat ion of H431 cells and cell ex trac ts
To R431 cells (in uiuo stimulation), EGF mas added at 
100ng/ml to culture medium 0.5-1 hour prior to haruesting 
the cells; For R431 cell extracts (in uitro stimulation), EGF mas 
added at 500ng/ml to the extracts in a binding buffer (50mM  
Tris-HCI/150mM NaCI, pH 7.5), and the mixture mas incubated 
on ice for 10 min prior to be labelled mith m uitro (i.e. in 
uitro stimulation of the extracts mith EGF mas follomed 
im m ediate ly  by in uitro phosphorylation of the same 
extracts).
3. In uitro phosphorylation
10|il of cell extracts mas Incubated mith 2-5iiCi of (Y- 
32p)RTP in an in uitro phosphorylation buffer (25mM Tris-HCI, 
10mM MnClz, 0.5mM EGTR, 50|iM Na3Ü04 and 20|iM ZnSO  ^ at pH 
7.5) on ice for 30 min. Immediately a f te r  that, the reaction 
mix mas Immunoprecipitated mith an antiserum to DBP or 
Ptyr. For mestern blotting, 250jiM of RTP mas used as 
phosphate donors instead of (Y-32p)nTP. Immediately a f te r  
phosphorylation, the mixtures mere denatured in sample 
buffer  (100OC, 3 min), separated by SDS PRGE and blotted to 
nitrocellulose f i lter paper, follomed by probing mith antisera.
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4. Im m u n o p ré c ip i ta t io n
32p-labeled cell extracts mere incubated mith 5\i\ of 
antisera on ice for 2 hours. After mhich, 100^ x1 of Staph H 
(fixed Staphylococcus aureus of Coman R strain in a 10% m/u  
suspension) mas added and the mixture mas incubated for a 
further 30 min on ice. Immune complexes absorbed to Staph R 
mere then isolated by centrifugation at 2500g for 3 min 
(bench microcentrifuge) and mashed three times mith 
mashing buffer (20mM Tris-HCI/0.65M NaCI/ Im M  EDTR/0.5% 
N P 4 0 /10% Sucrose at pH 7.5). The proteins in the complexes 
mere dissociated by boiling in sample buffer and analysed by 
SDS PRGE follomed by autoradiography.
5. Protein tyrosine kinase assay
Radioactiue fi lter assay (Bomen et al, 1991) 4^1 (10|ig) of cell 
ex tra c ts  mere incubated mith Ijj I^ (15jj,g) of RR-SRC 
(synthesised by Paul Talbot) and 1}iCi of T-RTP in a 20|xl uolume 
containing 30mM Hepes (pH7.4), 10mM MgClz, 0.1mM DTT, 
25jig/ml BSR, 0.15% NP40, 70|iM Na3U04 and 60|iM RTP on ice 
for 30 min. Rfter mhich, 120{il of 5% (m/u) trichloroacetic acid 
(TCR) mas added and the mixture mas ieft on ice for 1 hour 
before centrifugation at 12,000g for 10 min. 20^1 of the 
supernatant mas spotted onto a phosphocellulose disc (cut 
from a IDhatman p81 phosphocellulose paper). The discs mere 
mashed tmice mith 1% (u/u) acetic acid, tmice mith mater, air 
dried, placed in 5 -1 0ml of scintillation fluid and counted (TRI- 
CRRB 300 Liquid Scintillation System, Canberra Packard). 
Nonradioactiue ELISR (Lazaro et al, 1991) R 96-mell  ELISR 
plate mas treated  mith 1% Glutaraldehyde (Sigma, 25%
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solution) and mashed in PBS prior to use. Poly (Glu.Na, Tyr) 4:1 
(Sigma) mas absorbed to the pretreated plate at IQng/ml in 
PBS ouernight at 4°C. The plate mas mashed mith PBS, blocked 
mith 5% Maruel/PBS (3?oc, 30 min), and 50 i^l of assay buffer  
(50mM Hepes, 150mM NaCI, 10mM MgC^, 5mM NaF, 50|iM 
Na3Ü04, 0.8mM EGTR, 0,2mM EDTH and 300}iM RTP at pH 7.4) 
mas added follomed by 50|il of cell extract diluted in assay 
buffer containing no RTP. The phosphorylation reaction mas 
carried out at 37°C for 30 min. Rfter mhich, the piate mas 
mashed mith PBS and a n t i -P ty r  antibody (diluted in 5% 
Maruei/PBS) mas applied (37°C, 1 hour) follomed by incubation 
mith peroxidase-labeled secondary antibody (37<^C, 30 min). 
Finally, phosphorylated tyrosine mas uisualized by color 
deuelopment.
6 . iodination of DBP (Ruyechan and Olson, 1992)
1ml of each purified DBP (early 300|ig/ml, late 800^g/ml  
and baculo-uiral 400|xg/ml) mas dialyzed against 0.1M sodium 
borate (pH 9.5) for 2h at 4°C. The resulting 2ml of protein 
solution mas split into four 0.5ml fractions. Of mhich, three 
fractions mere treated mith 1.25^1, 2.5|al and 5|xl of KI3 (0.05M 
I 2 in 0.24M Kl), and one fraction mas treated mith 5|il of H2O 
(as a control). The reaction mixtures mere incubated on ice for 
20 min and the reaction mas stopped by the addition of 15|il 
of 1M NaHSD4. lodinated and control protein fractions mere 
then dialyzed against 10mM Tris-HCI (pH 7.5), 150mM KCI, 
Im M  EDTR, 0.1 mM DTT, 20|xg/ml PMSF and 50% Glycerol 
ouernight at 4°C.
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7. Gel shirt DNR binding assay (Stuiuer et al, 1992)
25-20Qng of DBP (untreated or lodinated) mas incubated 
mith \\l[ of 3zp labelled ssDNR oligonucleotide (IBbp from Rd2 
origin, 100 counts/min) in 25mM Hepes (pH 7.4), 100mM NaCI, 
Im M  DTT, 5mM MgClz, 0.01% (u/u) NP-40 and 0.1 mg 
(binding buffer) in a total uolume of 20|il on ice for 15min. 
Then, 5m,I of 5« DNR sample buffer  (50mM T r is -b o ra te / Im M  
EDTR/0.02% Bromophenol blue/50% Glycerol at pH 8.3) mas 
added and the reaction mix mas loaded onto a 6% 
nondenatured acrylamide/bisacrylamide gel, mhich mas 6% of 
acryiamide:N,N'methylene-bisacryiamide (44:0.8 m /m )  in 
50mM Tris-borate/0.1% (NH4)2S2O8/0-l 2% TEMED at pH 8.3. The 
electrophoresis mas carried out at 200^ of constant uoltage 
for 1 -2.5h at 4°C. Rfter that, the gel mas fixed by DERE paper, 
dried and exposed to Fuji H-ray film.
Results:
1. Tyrosyi-phosphory ia t lon  of DBP during Rd2 infection  
It mas suggested that DBP is tyrosyl-phosphorylated 
early a f te r  infection. In uiuo labelling of Rd2 infected 
Hela cells at different post-infection times shomed that  
the degree of labelling of the DBP Increased up to 
relatiuely late times mhile the proportion of alkaii-resistant  
phosphorylation mas greatest at the early infection times 
(Russeil et al, 1989). To confirm this, DBP phosphorylation 
mas carried out in an in uitro system and phosphorylation 
of DBP mas determined by immunoprécipitation using 
rabbit polyclonal antibodies against DBP and Ptyr as
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follOLus: Hela monolayer cells mere infected mith Hd2 at 20 
p.f.u/cell  and extracted In an in uitro phosphorylation buffer  
at post-infection (p.I) of 12 hours (h), 18h, 24h, 30h and 36h. 
in uitro phosphorylation mas carried out by incubating 10^1 of 
each infected cell extract mith 2.5 p.Ci of (Y-32p)nTP on ice for  
30 min. 3zp labelled extracts mere then parallelly precipitated 
mith anti-DBP and anti-Ptyr antibodies (Fig.11-1). Figure 11-1 
shoms that DBP mas phosphorylated during the time course of 
Hd2 infection (Lanes 1-5) but phosphotyrosine mas not 
detected in phosphorylated DBP during infection (Lanes 6-10),  
suggesting that tyrosine phosphorylation of DBP may not be 
represented in an In uitro system.
In an immunofluorescence assay, a time course of Ad2 
infected Hela cells mere fixed, penetrated and probed mith 
antibodies against DBP and Ptyr follomed by immunostain 
mith fluorescence labelled secondary antibody. DBP appeared 
in some infected cells as early as 6 hours but phosphotyrosine 
mas not detected during the course of 3-48h p.i (data not 
prouided), suggesting that there is no detectable increase in 
phosphotyrosine leuel in Hela cells during Rd2 infection and if 
DBP is phosphorylated early a f te r  infection, the signal of Ptyr 
mould be too lom to be detected in this assay.
2. In uitro tyrosine phosphorylation of purif ied  DBP
Phosphotyrosine of DBP mas not detected in crude Hd2 
infected cell extracts a f te r  in uitro phosphorylation. Hom 
about purified DBP? Can it be phosphorylated at tyrosine in 
uitro? To ascertain mhether DBP is a substrate of protein 
tyrosine kinases, In uitro phosphorylation of purified DBP mas
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performed using Rd2 Infected and mock-infected Hela cell 
extracts and EGF stimulated R431 cell extracts as different  
sources of tyrosine kinases. Uninfected and Rd2 infected Hela 
cell extracts serued as crude cellular and uiral kinases mhile 
EGF stimulated R431 cell extracts presented mainly receptor
3 4 5 6 7 8 9  10 11
DBP—
Fig.11-1. Rutoradiography of a time course of Rd2 infected 
Hela cell extracts immunoprecipitated mith antibodies against 
DBP and Ptyr a f ter  the extracts haue been labelled mith 3Zp m 
u it ro .  The e x t r a c ts  In lanes 1 -5  and 11 m ere  
immunoprecipitated mith an anti-DBP antibody and the 
extracts in lanes 6-10 mere immunoprecipitated mith an anti-  
Ptyr antibody. Lanes 1&6: 12h p.i; Lanes 2D7: 18h p.i; Lanes 
38'8: 24h p.i; Lanes 409: 30h p.i; Lanes 5010: 36h p.i; Lane 11: 
purified DBP mas added to 24h p.i extracts.
(EGFR) kinase since R431 cells contain uery high leuel of 
receptors specifically to EGF. These receptors possess a 
tyrosine kinase actiuity and this actiuity is increased (seueral 
fold) upon binding to (stimulating mith) EGF. EGFR itself  is 
autophosphorylated at seueral sites of tyrosine residues,
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prouiding not only a tyrosine kinase but also a substrate for  
tyrosine kinase. Phosphorylated EGFR has an apparent  
molecular meight of about 175K in SDS gel. Rfter labelling of 
R431 cell extracts and Rd2 infected or mock-infected Hela cell 
extracts  mith the reaction mixes mere parallelly
immunoprecipitated mith anti-DBP and ant i -P tyr  antibodies, 
and separated by SDS PRGE follomed by autoradiograph(Fig.lI- 
2). From figure 11-2, it can be seen that phosphorylated DBP 
only presented in the samples immunoprecipitated mith anti-  
DBP antibody (Lanes 3, 6 , 8 ,1 1  and 13) but not mith anti-Ptyr  
antibody (Lanes 4, 7, 9, 12 and 14) mhile tyrosine  
phosphorylated EGFR mas immunoprecipitated mith anti-Ptyr  
antibody as expected (Lanes 12 and 14). This suggests that  
although purified DBP can be phosphorylated in uitro by both 
cellular (Lanes 3, 11, and 13) and uiral (Lane 8) kinases it may 
not be a substrate of tyrosine kinases since it mas apparently 
not tyrosyl-phosphorylated by Hela cellular kinases (Lane 4), 
uiral kinases (Lanes 7 and 9) and crude EGFR (Lanes 12 and 
14).
R similar experiment mas carried out by mestern blotting 
and the same results mere obtained (Fig.11-3; Fig.11-4). In 
mestern blotting, purified Ü-DBP (mild type uiral DBP) and B- 
DBP (DBP expressed in Baculouirus) mere incubated mith Rd2 
infected Hela cell extracts and EGF stimulated R431 cell 
e x t ra c ts  in the presence of RTP. R f te r  in u itro  
phosphorylation, the samples mere separated by SDS PRGE, 
blotted to nitrocellulose f i l te r  paper and probed mith both 
anti-DBP (R) and anti-Ptyr (B) antibodies. Figures 11-3 and 11-4
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shorn that  EGFR (in R431 cell ex trac ts )  mas ty ros y l -  
autophosphorylated (Fig.11-3.B. Lanes 5 & 8; Fig.11-4.B. Lanes 
1 2 3 4 5 5 7 8 9 10 1 1 12 13 14 15
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Fig .11-2. Rn autoradiography of in uitro phosphorylation of 
purified DBP immunoprecipitated mith anti-DBP and anti-Ptyr  
antibodies.  Lanel (2): un in fectedH eia  cell e x t ra c ts
immunoprecipitated mith anti-DBP(anti-Ptyr) antibody; Lane 3 
(4): uninfected Hela cell ex t ra c ts  plus purif ied  DBP 
immunoprecipitated mith anti-DBP (anti-Ptyr) antibody; Lane 
5: the same sample as lanes 3 and 4 but immunoprecipitated 
mith a control rabbit antiserum (anti-SU5); Lane 6 (7): infected 
Hela cell extracts immunoprecipitated mith anti-DBP (anti-  
Ptyr) antibody; Lane 8 (9): infected Hela cell extracts plus 
purified DBP immunoprecipitated mith anti-DBP (anti-Ptyr)  
antibody; Lane 10: control antiserum to SU5; Lane 11 (12): EGF 
stimulated R431 cell membrane extracts plus purified DBP 
immunoprecipitated mith anti-DBP (anti-Ptyr); Lane 13 (14):
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EGF stimulated R431 cell solubilized extracts plus purified DBP 
Immunoprecipitated mith anti-DBP (an t i -P tyr j ;  Lane 15: 
control antiserum to SU5.
211 K --
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F ig .11-3.  LUestern blotting of purified DBP a f te r  in uitro 
phosphorylation. R: The blot mas probed mith an anti-DBP 
antibody. B: The blot mas probed mith an anti-Ptyr antibody. 
Lane 1: uninfected Hela cell extracts; Lane 2: infected Hela cell 
extracts; Lane 3 (6): purified U-DBP (B-DBP); Lane 4 (7): 
infected Hela cell extracts plus purified DBP (B- DBP); Lane 5 
(8): EGF stimulated R431 cell solubilized extracts plus purified 
U-DBP (B-DBP).
1 C» 2) in this assay system, but both purified U-DBP (Fig.11-3. 
B. Lanes 4 0  5; Fig.11-4.B. Lane 2) and B-DBP (Fig.11-3.B. Lanes
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7 0  8) mere not, suggesting that purified DBP may not be a 
substrate for tyrosine kinase in uitro. It mas also shomn in 
Fig.ll-3.B that purified DBP does not contain phosphotyrosine
A.  I 2  ^ 1 2
eOPR—  k w L
PBP—  mm
Fig.11-4. IDestern blotting of purified DBP a f te r  in uitro 
phosphorylation by EGF stimulated R431 cell membrane  
extracts. R: probed mith anti-DBP antibody; B: probed mith 
an t i -P tyr  andtibody. Lane 1: membrane extracts; Lane 2: 
membrane extract plus purified DBP.
(Lanes 3 0  6), suggesting th a t  i f  DBP is ty ro s y l -  
phosphorylated in uiuo, it may be dephosphorylated at 
tyrosine during the extraction and purification process.
3. In ultra tyrosine phosphoryiatlan of peptide DBP195
DBP mas shomn (Russell et al, 1989) to be tyrosyl-
phosphorylated by in uiuo labelling the DBP mith 3Zp and
the putatiue tyrosine phosphorylation site mas suggested 
to be at Tryigs. By in uitro (Russell et al, 1989) labelling 
the DBP mith 32p^ DBP mas not shomn to be 
phosphorylated at tyrosine (Fig.11-1, 2, 3, and 4). To find 
out mhether the primary sequence of DBP that contains
the putatiue tyrosine phosphorylation site (Tyrigs) is
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phosphorylatable, a peptide DBPPT195 (RRHLMDKVHUDNDL) Luas
250001
Pos.Con.
Neg.Con.1
Neg.Con.2
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O 15000:  w
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T
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F ig . i i -5 .  R time course of in uitro phosphorylation of peptide 
DBP PT195. Pos.Con: positiue control of EGF stimulated R431 
cell soluhilized extracts mith peptide RR-SRC; Neg.Con.1: 
negatiue control of EGF stimulated R431 cell soluhilized 
extracts mith peptide containing no tyrosine (ETGGUHLDS); 
Neg.Con.2: negatiue control of EGF stimulated R431 cell 
soluhilized extracts mith no peptide; 0BPPT195: EGF stimulated 
R431 cell soluhilized extracts mith peptide DBPPT195. R. 
Presentation of cpm counts of all the samples a f te r  spotting 
onto nitrocellulose and mashing mith PBS. B. To prouide a
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be t ter  uieui of DBP PT195 phosphorylation, graph of Pos.Con. 
mas mithdramn from the figure.
synthesized from the sequence of Rd2 DBP (aalBB-aaZQI) and 
an in uitro phosphorylation of this peptide mas performed  
using R431 cell solubilized extracts as crude tyrosine kinases 
(containing mainly EGFR receptor kinase). Fig.11-5 shoms the 
result that it mas phosphoryiated although the extent of its 
phosphorylation mas much lomer than the peptide RR-SRC 
(F lg .i i -5) .  This could be because RR-SRC probably binds to 
phosphoceilulose paper better  than 0BPPT195 since it contains 
tmo arginine residues at the end mhile 0BPPT195 does not.
4, Tyrosine kinase assay on Rd2 in fected  Hela ceils
In an in uitro system, DBP mas not shomn to be tyrosine-  
phosphorylated in crude cell extracts and in a purified form as 
described aboue. But a peptide selected from the DBP 
sequence that contains a putatiue tyrosine phosphorylation 
site mas shomn to be phosphoryiated in uitro by a crude 
receptor kinase (Fig.11-5). This implicates a potential that DBP 
may be tyrosyl-phosphorylated in uiuo mhen this site (Tryigs) 
is accessible to tyrosine kinases under certain circumstance. 
To find out mhether there is an increase in tyrosine kinase 
actluity in Rd2 infected Hela cells, an in uitro phosphorylation 
mas performed using synthetic peptide RR-SRC. RR-SRC 
(RRLiGDREVRRRG) an artificial substrate for seuerai tyrosine 
kinases, generated from a tyrosine phosphorylation site in 
p p6 0 src (casneliie et ai, 1982). To test mhether tyrosine 
kinase actluity increases in Rd2 infected Hela cells, peptide 
RR-SRC mas incubated mith Rd2 infected and mock-infected
Hela cell extracts in an in uitro phosphorylation buffer in the 
presence of ys^P-ATP. fls a comparison, RR-SRC mas also 
incubated mith EGF stimulated and mock-stimulated R451 cell 
membrane extracts. After ^2p labeling, the proteins in the 
reaction mix mere remoued by acid precipitation and tyrosyi-  
phosphorylated peptide (RR-SRC) mas adhered to a 
phosphoceilulose paper and counted for  radioactiuity in 
scintillation fluid (Fig.11-6). From figure l i - 6, it can be seen 
clearly that tyrosine kinase actluity mas not increased in Rd2 
infected Heia ceils at both early and late times, in fact it 
appeared that Rd2 infection slightly domn-regulated cellular 
tyrosine kinase actluity (Fig.11-6, B). It has been reported  
(Carlin et al, 1989; Herheijden et al, 1992) that group C human 
adenouiruses domn-regulate EGFR of a uariety of cell types 
early a fter  infection. Hela cells contain uery iom leuel of EGFR 
(Hunter and Cooper, 1981), and mhether this little decrease in 
actluity could be attribute to EGFR or not is not clear.
R similar experiment mas carried out by ELiSR using an 
artificial substrate of poly (Glu.Na, Tyr) 4:1 and a similar result 
mas obtained (data not prouided): there mas apparently no 
increase in actluity of tyrosine kinase in Rd2 infected Hela cell 
extracts.
Since peptide DBPPT195 can be phosphoryiated by EGFR 
(Fig.11-5) and its sequence mas selected from DBP containing 
a putatiue tyrosine phosphorylation site, mill it serue as a 
better  substrate for uiral tyrosine kinase? The same kinase 
assay as mith peptide RR-SRC mas repeated using peptide 
DBPPT195 and no tyrosine kinase actluity mas found in both 
uninfected and Rd2 infected Hela cells (data not shomn).
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F ig .1 1 -6 .  A time course of szp-incorporation in RR-SRC 
peptide by Rd2 infected and mock-infected Hela cell extracts. 
Pos.Con: positiue control of EGF stimulated R431 ceil 
solubilized extracts; Neg.Con.1: negatiue control of EGF 
stimulated R431 cell solubilized extracts mith a peptide 
containing no tyrosine; Neg.Con.2: negatiue control of EGF 
stimulated H431 cell solubilized extracts mith no peptide; 
Uninf: u n in fe c te d  Hela ceil e x t ra c ts ;  In f /E :  Rd2
infected/hydroxyurea blocked Hela cell extracts; Inf/L: Rd2 
infected unblocked Hela cell extracts, fl. Presentation of cpm 
counts of all the samples. B. To make a better  comparison, 
graph Pos.Con. mas remoued from Fig.fl.
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5= EGF e f f e c t  on ty ro s in e  k in ase  a c t lu i t y  o f  Hd2 
in fec ted  Hela cells
It is knouin that EGF stimulates tyrosine kinase actluity 
of EGFR significantly. To test mhether It affects tyrosine 
phosphorylation of Rd2 infected and mock-infected Heia cells 
(mould phosphotyroslne signal be increased by an increased 
tyrosine kinase actluity if DBP is tyrosine-phosphorylated but 
the signal is too Iom to be detected under the conditions 
mentioned aboue?). Rd2 infected and mock-infected Hela cells 
mere incubated mith 100ng/ml EGF in culture medium for 1 
hour at 37°C (in uiuo stimulation) prior to being extracted.  
After extraction, Hela cell extracts mere separated by SOS 
PAGE and probed mith anti-DBP and ant i -P tyr  antibodies. It 
appeared (Fig.11-7) that in both uninfected and Ad2 infected 
Hela cells there mas no difference in tyrosine phosphorylation 
pattern betmeen EGF stimulated (Lanes 2 and 4) and mock- 
stimulated (Lanes 1 and 3) cells. This mas repeated (data not 
shomn) mith similar results mhen cells mere stimulated mith 
EGF in uitro (i.e. cell extracts mere incubated mith EGF prior to 
phosphorylation). From these results, it suggests that EGF 
does not affect tyrosine phosphorylation of uninfected and 
Ad2 Infected Hela cells, and the phosphotyroslne signal in DBP 
mas not increased (presuming It mas present) by stimulating 
the infected cells mith EGF in uiuo and in uitro.
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F i g . M - 7 .  LUestern blotting on fldZ infected and mock-  
infected Hela cells. H: probed mith an anti-DBP antibody; B: 
probed mith an anti-Ptyr antibody. Lanel: uninfected extract; 
Lane 2: in uiuo EGF stimulated uninfected extracts; Lane 3: 
infected extract; Lane 4: in uiuo EGF stimulated infected  
extracts.
Discussion:
1. Inab i l i ty  to detect  P tyr  in DBP
Using anti-Ptyr polyclonal antibody, DBP mas not detected 
to be phosphoryiated at tyrosines in an immunofluorescence 
assay and in an in uitro phosphorylation system by 
im m unopréc ip ita t ion  and m estern  b lo tt ing .  Probably  
phosphotyroslne leuel is too Iom to be detected and in this 
regard immunoprécipitation and mestern blotting methods 
are not sensitiue enough. Probably tyrosyl-phosphorylation 
turns on and off rapidly, it mas reported (Kamps and Sefton, 
19BB) that  phosphoryiated tyrosine residues can be 
dephosphoryiated during immunoprécipitation because of the 
presence of actiue phosphatases under this condition. 
Probably  in an im m u n of lu o re sc en ce  assay, some
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phosphotyroslne residues (on the protein) are stericaiiy or 
conformationally hindered from binding to antibody, or 
perhaps that uicinal charges on the protein interfere mith 
antibody binding (Frackelton er ai, 1983); in this regard the 
use of a polyclonal antibody may be better than a monoclonal 
antibody. Probably in a mestern blotting assay, a f te r  SDS- 
PRGE and t ra n s fe r  to nitrocellulose f i l t e r  paper, the  
accessibility of an antibody to phosphotyroslne mould be 
changed (Linder and Burr, 1988). Apart from ail these  
possibilities, an important factor could be that an in uitro 
system is not equiuaient to an in uiuo system and cannot 
represent the actual situation in uiuo (Fujita-Yamaguchi et ai, 
1989).  I t  is also possible th a t  DBP might be not 
phosphoryiated in uitro.
Z .Tyrosyl-phosphory lat lon  of DBP— does it take  place?
It is not surprising that purified DBP failed to be 
phosphoryiated at tyrosine by crude EGFR extract in uitro 
mhile a peptide selected from the DBP sequence containing 
the putatiue tyrosine phosphorylation site mas shomn to be 
phosphoryiated. UJhen a peptide contains a tyrosine mhich is 
surrounded by acidic residues, it is likely that the tyrosine 
mould be phosphoryiated by a tyrosine kinase. This is not 
necessary true in a protein, since the accessibility of the 
target amino acid to the kinase is gouerned by secondary or 
tertiary structure of the protein. In this regard, it is possible 
that DBP could be phosphoryiated in uiuo but may not in uitro 
and uice uersa. In an in uiuo situation, the conformation of 
DBP could be changed as the state of infection changes.
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ailoLüing the phosphorylation site of tyrosine to be exhibited 
or sheltered. Presuming DBP is phosphoryiated In uiuo (in 
some stage e.g. early a f t e r  infection) as suggested in 
preuious study, mhat possible roles mould it play?
The inuoluement of tyrosine side chains In ssDNB binding 
of prokaryotic single-stranded ONfl-blndIng protein has been 
demonstrated by the study of T4 bacteriophage gene 32 
protein (Karpel, 1990), a non-sequence specific ssDNfl binding 
protein mhich has serued as a model of this class of protein 
and is mell characterized. There are eight tyrosines In T4 gene 
32 protein. Tmo of them haue a structural function (stabilize 
the tert iary structure of the protein) mhile the remaining six 
are shomn to be inuolued in ssDNR binding (each contrubutes 
to the ouerall affinity of protein for DNfl). it is proposed that 
a discrete group of tyrosine residues may form regularly 
spaced hydrophobic pockets (a "ladder-like" binding grooue) 
into mhich the heterocyclic rings of the oligonucleotide bind. 
There are six tyrosines in the C-terminal of DBP (for Rd2, Rd4 
O' Rd5) and three of them (corresponding to Try 195, Try380 & 
Try455) are highly conserued among ail serotypes (Fig.i 1-8). 
From figure i 1-8, it appears that ail the tyrosines in C- 
terminai are distributed in a similar may at discrete sites. Rre 
these tyrosines inuolued in ONR binding of DBP? lUouid it be 
possible that tyrosine phosphorylation of DBP indirectly  
regulates the ouerall affinity of the protein to DNfl by altering 
the local hydrophobic state of the "binding grooue" of the 
protein?
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Ad2 174 SLPIVSAWEKGMEAARALMDKYHVDNDLKANFKLLPDQVEALAAVCKTWLNEEHRGLQ 
Ad4 153 SLPI VSAWEKGMEI MNMLMERYRVESDLKSNFQLMPEQGEVYR RICH LYINEEHRGIP 
Ad5 174 SVPI VSAWEKGMEAARALMDKYHVDNDLKANFKLLPDQVEALAAVCKTWLNEEHRGLQ 
Ad7 159 SLPI VSAWEKGME VMAVLMERYRLDNDLRTSFKLMPEQHEQYKRI CHQYVNEEHRGIP 
Adi 2 129 SQPLVSAWEKGMEAMAMLMEKYHVDHDERATFRFLPDQGSVYKKICTTWLNEEKRGLQ 
Ad40 120 AEPLVSAWEKGMDLM I KLMEKYHVEAEEKNGFKFLPEQSNVYRKICQTWLNEEHRGLP 
Ad41 121 VDPLVSAWEKGMELM NVLMEKYHVENDEKTAFKFLPEQNAVYRKICQTWLNEERRGLS
Ad2 232 LTFTSNKTFVTMMGRFLQAYLQSFAEVTYKH HEPTGGALWLHRCAEIEGELKCLHGSI 
Ad4 211 LTFTSNKTLTTMMGRFLQGFVHAHSQiAHKNWESTGCALWLHGCTEVEGKLRCLHGTT 
Ad5 232 LTFTSNKTFVTMMGRFLQAYLQSFAEVTYKH HEPTGGALWLHRCAEIEGELKCLHGSI 
Ad7 217 LTFSSMKTLTAMMGRFMQGLVHSYSEIAHHNWECTGCALWAHGCTDYEGKVKCLHGTl 
Adi 2 187 LTFSSQKTFQELMGRFLQGYMQAYAGVQQNSWEPTGCCVWEHKCTEREGELRCLHGME 
Ad40 178 LTFTSHKTFVEMMGRFLRAYVESYAGVKNNEWEPTGCAIWLHGCTEQEGVLRCYHGLE 
Ad41 179 LTFTTQKTFTE LMGRFLAAYVETYAGVKHHNWDTTGCAVWAHGCTREEGVLRCFHGRE
Ad2 290 MINKEH VIEMDVTSENGQRALKEQ SSKAKI VKNRWGRNVVQISNTDARCCVHDAACPA 
Ad4 269 MIQKEHMIEMDVASENGQRALKENPDRAKVTQNRWGRSVVQLANNDARCCVHDAGCAT 
Ad5 290 MINKEH VIEMDVTSENGQRALKEQ SSKAKI VKNRWGRNVVQISNTDARCCVHDAACPA 
Ad7 275 MIQKDHIIEMDVASENGQRAMKENPDRAKITQNRWGRNWQLANNDARCCVNDANCAT 
Adi 2 245 MVRKEHLVEMDVTSESGQRALKENPSKAKVAQNRWGRNVVQIKNDDARCCFHDVGCGN 
Ad40 236 Ml QKEQLVEMDVASENAQRALKEHPSRAKVVQNRWGRSVVQLKNDDARCCVEDVSCAT 
Ad41 237 MIQKEQVVEVDVGSENGQRALKEQPSKTKVVQNRWGRSVVQIKNDDARCCAEDVSCGN
Ad2 348 NQFSGKSCGMFFSEGAKAQVAFKQIKAFMQALYPNAQTGHGHL-LMPLRCECNSKPGH 
Ad4 327 NQFSSKSCGVFFTEGAKAQQAFKQLEAFMKAMYPGMNADQAQVMLIPLHCOCNHKPGC 
Ad5 348 NQFSGKSCGMFFSEGAKAQVAFKQIKAFMQALYPNAQTGHGHL-LMPLRCECNSKPGH 
Ad7 333 NQFSSKSCGMFYTEGIKAQEAFKQYEAFMKAVYPGITPDQARMMLIPIHCDCNHKPGC 
Adi2 303 NSFSGKSCGLFYSEGMKAQIAFRQI EAFMLADYPHMRHGQKRL-LMPVRCECLNKQDG 
Ad40 294 NVFSAKSCGLFFSEGTKAQTAFLQIEAFMQAEYPKMQNGLKRL-LMVMRCDCLYKPTG 
Ad41 295 NMFSSKSCGLFFSEGLKAQIAFKQMQAFLQAEYPQMQRGQQRI-LVPLRCECLNKKDL
Ad2 405 APFL GRQLPK LTPFA LSNAEDLDADLISD KSVLASVHHPALIVFQCCNPVYRNSRAQG 
Ad4 385 VPTMGRQTCKMTPFGMANAEDLDVDGITDATVLASVKHPALMVFQCCNPVYRNSRAQN 
Ad5 405 APFL GRQLPK LTPFA LSNAEDLDADLISD KSVLASVHHPALI VFQCCNPVYRNSRAQG 
Ad7 391 APVMGRQTCKMTPFGMANAEDLDVATISDPTVLASVRHPALMVFQCCNPVYRNSRVQN 
Ad12 360 LPRM GRQLCKl TPFN L SNVDNl Dl NEVTDPGALASIKYPCL LVFQCANPVYRNARGN 
Ad40 351 VPQLGROMCKATPFA LSN VDSLRAEEVTDKVALASIQYPCVLVYQ CANPVYRNSRGG 
Ad41 352 VPQLGRQMCKVTPFA LSG AEDLK TSEVTDKSALASI LHPCVLVFQ CANPVYRNSRGS
Ad2 463 GGPNCDFKISAPDLLNALVMVRSLWSENFTE-LPRMVVPEFKWSTKHQYRNVSLPVAHS 
Ad4 443 AGPNCDFKISAPDLLGALQLTRKLWTDSFPDTLLPKLLIPEFKWLAKYQFRNVSLPAGHA 
Ad5 463 GGPNCDFKISAPDLLNALVMVRSLWSENFTE-LPRMVVPEFKWSTKHQYRNVSLPVAHS 
Ad7 449 AGPNCDFKISAPDLLGALQLTRKLWQDTFPEIPVPKLVIPEFKWQNRLQFRNVSLPAGHY 
Adi2 418 AGPNÇDFKJSAPDVMGALQLVRQLWGENF-DGSPPRLVIPEFKWHQRLQYRNISLPTNHG 
Ad40 409 QGPNCDFKISAPDLLGALQLVRRLWGENV-DGPLPKMLIPEFKWSSRLQYRNVALPASHG 
Ad41 410 AGPNCDFKISAPDVISALQLVRQFWKENV-EDPLPKLllPEFKWSTRLQYRNVALPTGHG
F i g . M - 8 . Comparison of tyrosine (boid) distribution in C- 
terminai of Hd DBFs. Four conserued regions are underlined 
(CR1:178-186; Zinc finger domain: 273-286; CR2:322-330; CR4: 
464-475).  (from Uos et al, 1988).
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Based on the knouin specificity of the reagent, chemicai 
modification of a protein is a simple method to identify the 
inuoluement in ONR binding of a particular amino acid 
(Bandyopadhyay and lilu, 1978). Under mild conditions, the 
reaction of Iodine mith protein modifies primarily tyrosines, 
leading to the iodlnation of the phenolic moiety in tyrosine 
and resulting in the ioss of hydrophobic interactions betmeen 
phenolic moiety of the tyrosine and the aromatic bases of the 
polynucleotide (Shamoo et al, 1987). LUhen DBP mas iodinated 
mith Kis at molar ratios of K I3 : DBP of 25:1, 50:1 & 100:1 
(corresponding to molar ratio of K I3 : Try in Rd2 DBP of 4:1, 8:1 
& 16:1 respectiuely), the ssDNA binding actluity of DBP mas 
completely abolished (F ig . l i -9 ) ,  suggesting that  these  
(accessible to modification) tyrosines of DBP mere inuolued in 
ssDNR binding. UJestern blotting of untreated and iodinated 
DBP mith MRb 12B8 shomed (Fig.i i -10) that the antigenic site 
and the size of the DBP had not been altered by this 
modif ication, suggesting that  iodlnation under these  
conditions did not denature the protein and the antigenic site 
recognized by MRb 12B8 may be not located near these 
tyrosines. This is in agreement mith the result that MRb 
(12B8) binding of DBP did not a f fe c t  its DNR binding. 
Comparing preuious results ( see introduction 3.3), Trysie 
(conserued) Is mithin the C-terminal 46 amino acids mhich has 
been shomn to abolish DNR binding mhen deleted (Uos et al, 
1988a) and Try4S5 (highly conserued) has been reported to be 
a third putatiue contact point mith DNR by photochemical 
cross-linking (Cleghon and Kiessig, 1992) and its location is 
uery close to the conserued region 3 (CR3: 464-475) mhich has
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1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Fig .11-9. Gel re tardation assay of untreated and iodinated 
DBP. Lanel : probe (^2p labelled ssDNR); Lanes2-5: 200ng, 
100ng, 50ng & 25ng of untreated (control) e-DBP; Lanes6-8: 
200ng, 100ng & 50ng of iodinated e-DBP (KIsiDBP of 25:1); 
Lanes 9-10: 100ng of iodinated e-DBP (K i3:DBP of 50:1 0  
100:1); Lanel 1: 100ng of untreated i-DBP; L an e l2-13: 100ng 
of iodinated i-DBP (Kl3:DBP of 50:1 & 100:1); Lane14: lOOng of 
untreated B-DBP; L an es i5-16: 100ng of iodinated B-DBP 
(K i3:DBP of 50:1 & 100:1). e: early, DBP mas purified from Rd2 
infected Hela cells in the presence of 10mM Hydroxyurea; i: 
late, DBP mas purified from Rd2 infected Hela cells in the 
absence of 10mM Hydroxyurea; B: DBP mas purified from 
Baculo-uirus.
been suggested to be inuolued in DNR binding by mutagenesis 
(Neaie and Kitchingman, 1989; 1990). Thus, these tmo 
tyrosines are most likely to be inuolued directly in the 
interaction mith DNR. Try388 is highly conserued but has not 
been reported to be related to DNR binding. Tryzsi and Tryzso 
are not conserued but they are close to the Zinc finger mhich 
has been suggested to be required for DNR binding (Eagle and 
Kiessig, 1992 and might be inuolued in DNR binding. Tryigs
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(highly conserued) is the putatiue tyrosine phosphorylation 
site and can be phosphoryiated in uitro in a peptide. Tryigs is 
located at the N-terminal side of C-terminai domain and is not 
fa r  from Tryzsi, Tryzeo ^  Zinc finger. Phosphorylation and 
dephosphorylation on Tryigs might there fore  indirectly  
regulate the function of DBP in DNfl binding in uiuo.
fl. B. C.
1 2 3 4  1 2 3 4  1 2 3 4
DBP
Fig .11-10. LUestern blotting of untreated and iodinated DBP. 
Lanel: untreated DBP; Lanes2-4: iodinated DBP (Kl3:DBP of 
25:1, 50:1 & 100:1 respectiuely). fl. early DBP; B. late DBP; C. 
Bacuio-uiral DBP.
3. Tyrosine kinases —  are they required fo r  Rd2?
Tyrosine phosphorylation is uery important for both cells 
and uiruses due to its control in signal transduction and 
protein function. In normal cells, the tyrosine kinase actluity 
is maintained at a certain ieuel. LUhen cells are transformed 
or infected by a uirus, this ieuei could be eleuated since many 
oncoproteins are tyrosine kinases themself  or possess a 
tyrosine kinase actluity. In fld2 infected Heia ceils, no 
increase in actluity of tyrosine kinase mas detected using a
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synthetic peptide substrate (RR-SRC). Rre tyrosine kinases 
required by Hd2? R uery simple experiment mas carried out by 
immunofluorescence using a tyrosine kinase inhibitor  
Genistein. In this experiment, Hela ceils mere gromn in 
muitimell slides and infected mith Hd2 (20p.f .u /celf)  as 
folloms: (1) in the absence of Genistein & Hydroxyurea: (2) in 
the presence of Genistein (50 j ig /m l)  but absence of 
Hydroxyurea; (3) In the presence of Hydroxyurea (10mM) but 
absence of Genistein. After 24h p.I, the cells mere fixed,  
penetrated and detected for DBP and Hexon using Mflbs to DBP 
and Hexon. In the case of (1), DBP and Hexon mere detected in 
euery cell (100%); in the case of (2), DBP mas detected in 
euery cell but Hexon mas only detected In about 30% of the 
total cells; in the case of (3), DBP mas detected (100%) but no 
hexon mas detected (data not shomn). DBP is an early euent 
of Ad infection (it mas synthesized before the onset of uiral 
DNR replication) mhiie the hexon is a late euent (it mas 
synthesized a f te r  the onset of uiral DNR replication). LUhen 
Rd2 DNR replication is blocked (e.g. in the presence of 
hydroxyurea), only DBP is produced. Genistein is an isofiauone 
compound originally isolated from the fermentation broth of  
Pseudomonas sp (Ogamara et al, 1986) and has been shomn to 
be a highly specific inhibitor for tyrosine kinases (Rkiyama et 
ai, 1987). LUhen Hela cells mere infected mith Rd2 in the 
presence of Genistein, DBP synthesis mas not affected but the 
synthesis of hexon mas partially inhibited. LUouid this imply a 
role of tyrosine phosphorylation in Rd2 DNR replication? LUouid 
this be related to tyrosine phosphorylation of DBP?
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it has been knomn for quite some time that DBP is heauiiy 
phosphoryiated early a f ter  infection and It has been proposed 
that the uarious phosphoryiated forms of DBP may carry out 
the different roles of this multifunctional protein. Hotueuer 
the role of phosphorylation of DBP is still a m a t te r  of 
conjecture. Mutation studies has suggested that the ouerall 
phosphorylation state of the protein may be important for its 
ouin expression (Morin et al, 1989). DBP is inuolued in fld 
transcription. It  interacts mith E1R, E2fl, E4 D MLP promoters, 
stimulating the transcription directed from these promoters 
(except E4) especially from MLP. lliould it be possible that  
DBP may act as an acidic transcript ional ac t iu i tor  in 
t ranscr ip t ion  (Lin and Green, 1991) and its ouerall  
phosphorylation state facilitates this function (prouiding an 
acidic region to interact mith other transcriptional factors)? 
LUouid it be possible that the phosphorylation state of DBP 
may be controlled by the phosphorylation/dephosphorylation 
of Tryigs (mhich in turn may be controlled by a uiral tyrosine 
kinase/phosphatase)? Early a f te r  infection, this tyrosine  
could be phosphoryiated, contributing to the conformation  
th a t  mould be fau o ured  by the in te ra c t io n  mith  
transcriptional factors and promoters mhile late a f te r  
infection , this tyrosine may be dephosphoryiated, prouiding 
the conformation that mould fauoured by the interactions  
mith replication proteins and DNR (the promoter of DBP gene 
is shifted mhen DNR replication started). It  is difficult to say 
mhether the reduced synthesis of hexon noted aboue is due 
to an inhibition of late gene transcription or a block of uiral 
DNR synthesis. Homeuer, from this simple experiment, the role
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that tyrosine kinases may play cannot be dismissed aithough 
there is no detectable increase in tyrosine kinase actluity in 
an Rd2 Infection.
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Part I I I  [«pressing DBP in E coll 
using pGEK-2T uector
The technology of DNR manipulation In uitro has deueloped 
to the Ieuei that many eukaryotic genes can be expressed in 
prokaryotes such as Escherichia coli IE, coil) (Marston, 1986). 
The basic approach used to express foreign genes in E coli is 
to insert the genes of interest into an expression uector then 
transform the uector (containing inserted foreign genes) into 
E. coil (Hanahan, 1983). pGER uectors are designed so that  
foreign polypeptides can be expressed in E coli as fusions at 
the C-terminus of sJ26, a 26K glutathione S-transferase (GST) 
encoded by the parasitic helminth Schistosoma Japonicum  
(Smith and Johnson, 1988). The aduantage of this system is 
that it ailouis expressed protein to be purified under non­
denaturing conditions by a f f in i ty  chromatography on 
immobilised glutathione. The pGEH-2T uector also contains 
sequences that encode protease cleauage sites specifically 
recognised by thrombin (Fig.111-1.(a)).
Methods:
1. Preparation of  pGEK-2T plasmid
Groujth of bacteria R colony of bacteria (strain JM1Q1) 
transformed by plasmid DNR pGER-2T (Pharmacia) ujas plated 
onto a Luria-Rgar plate containing 10O|ag/ml ampiciiiin and 
incubated ouernight at 37°C. Dne toothpick scrape of this mas 
transfered into a 2L flask containing 500ml Luria-Broth (LB) 
together mith 100|ig/ml ampiciiiin and incubated ouernight
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EcoRISTOPcodons(a )
foe
PsH
IqcZpGEX-1 
«^4 9 kb
EcoRV
ORI
(b ) Pro ly s  ser  Asp Pro Arg Glu Phe l i e  Val Thr Asp ***
pGEX-l CCA AAA TCG GAT CCC CGG pAA TTC. ATC GTG ACT GAC TGA CGA TCT G
Smal EcoRI
Thrombin
Pro Lys Ser Asp Leu Val Pro Arg* Gly Ser Pro Gly l i e  Bis Arg Asp ***
pGEX-21 CCA AAA TCG GAT CTG GTT CCC CGT GGA TCC CCG GGA ATT CAT CGT GAC TGA CTG ACG ATC TG
BaaHl Smal EcoRI
Factor X
Pro Lys Ser Asp Leu H e  Glu Gly Arg* Gly H e  Pro Gly Asn Ser Ser ***
pGEX-3X CCA AAA TCG GAT CTG ATC GAA GGT CGT G.GG ATC CCC GGG AAT TCA TCG TGA CTG ACT GAC GAT CTG
DamHI Smal EcoRI
F ig . i  1 -1 .  Structure of the pGEH uectors.(a).  Schematic 
representation of pGEK-1. The positions of EcoRi, BamHi and 
PstI restriction sites are indicated, (b). Nucieotide sequence 
of pGER-1, pGER-2T and pGEH-3H at the C terminus of the SJ26 
cDNfl. The position of Thrombin cleauage sites of pGER-2T is 
indicated (from Smith and Johnson, 1988).
in a shaker at 37°C, ailoming ceils to groui to stationary  
phase.
lysis of bacteria by alkali The ceils mere pelleted in 2n250mi 
bottles by centrifugation at 8,000 rpm for 10 min at 4^0 
(Beckman JAM). Each of the pellets mere then resuspended in 
9ml of 50mM Giucose/25mM Tris-HCI (PH 8 .0 ) /1 0m M  EOTfl 
foliomed by fu rther  addition of 1ml lysozyme (28mg/ml,
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freshly made in 0.2M Tris-HCI, PH 8.0) and placed on ice for 5 
min. After mhich, 20ml of 0.2M NaOH/1% SDS (freshly made 
from stock solution) mas added and the mln mas left on Ice 
for a further 5 min foliomed by addition of 10ml 5M KAc pH 
5.4. After 15 min incubation on ice, the mixture mas clarified 
in 50ml tubes by centrifugation at 12,500 rpm for 40 min at 
4°C (Beckman JA17). The supernatant mas then filte red  
through tmo layers of cheese cloth and transferred to a fresh 
tube containing 15ml Isopropanol. The mixture mas le ft at 
room tem pe ra tu re  fo r 15 min. Nucleic acid mas then  
precipitated from the supernatant by centrifugation at 12,500 
rpm for 5 min and the resulting pellet of plasmid DNfl mas 
mashed mith 70% ice cold ethanol, dried and resuspended in 
Im i of TE buffer (10mM Tris-HCI, Im M  EDTfl, PH 7.5). 
P u rif ic a tio n  o f crude plasm id DNfl by equ ilibrium  
centrifugation in CsCI-Ethidium Bromide gradients. 1.2g of 
caesium chloride (CsCI, Sigma) mas added to 1 ml solution of 
crude plasmid DNfl foliomed by the addition of 50|il of 
10mg/ml Ethidium Bromide (EtBr, Sigma). The mixture mas left 
in the dark at room tem perature for 5 min and clarified by 
c e n tr i fu g a t io n  at 12 ,000g  fo r  3 min (MSE bench 
microcentrifuge). The supernatant mas transferred to a 2ml 
Beckman polyallomer Quickseal tube, and the tube mas topped 
up and balanced mith TE/CsCI/EtOr and heat sealed. The 
plasmid DNfl mas centrifuged to equilibrium at 80,000 rpm 
ouernight at 20°C (Beckman TL100) and uisualised as a pink 
band. The plasmid band mas remoued by side puncture using 
21G hgpdermic needles.
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!Butanol extraction of EtBr Ethidium bromide mas remoued 
from the DNR solution by repeated extractions mith an equal 
uolume of n-Butyl-aicohol saturated mith H2O until the pink 
color had disappeared completeiy.
Isopronanol and Ethanol précipitation Tmo uolumes of mater 
mas added to the DNR solution to dilute the CsCI and allom the 
DNfl solution to mix mith isopropanol, of mhich, D.6-1 uolume 
mas added aftermards. f lfter standing at room tem perature  
for 20 min, the mixture mas spun at 12,000g for 5 min (MSE 
bench microcentrifuge). The precipitated DNfl mas mashed 
mith 70% ice cold ethanol and resuspended In 400|il H2O. 40|il 
(1 /1 0  uolume) of 3M Naflc (PH 4.8) and 1 ml (2 -3  uolumes) of 
Ice cold ethanol mere added. The mixture mas left at -20°C  
fo r 15 min and spun as before. The DNfl pellet mas then 
mashed, dried, taken up in 400|il m ater and stored at -20oc.
2. Polym arase chain reaction  (PCfl)
DBP genes of mhole length protein, N-term inal domain 
(amino acids 1-173) and C-terminal domain (amino acids 174- 
529) mere amplified by polymerase chain reaction (PCfl) (Saiki 
et al, 1988) using a DNfl thermal cycler (Techne Programmable 
Ori-Block PHC-1 ).
Primers Four oiigonucletides, mhose sequences mere selected 
from fld2 DBP genes (Fig 11-2), mere synthesized in an Applied 
Biosystems Model 381 fl DNfl synthesiser to form three pairs of 
primers used in PCfl. For mhole length protein, upstream  
primer is 5 -GCG CGG ATC CCG GGfl AGfl GGfl GCfl GCG CGfl ARC C-3" 
and domnstream primer is 5 -GCG CGfl ATT CCC CCC CflC CCTTGC 
CGT CTG CGC CGT T-3'; For N-terminal protein, upstream primer
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M A S R E E E Q R E T T P E R G R G A A R R P P T  25
M E D V S S P S P S P P P P  R A P  P K K R L R R R  50
L E S E D E E D S S Q D A L V P R T P S P R P S T  75
S T A D L A I A S K K K K K R P S P K P E R P P S  lOO
P E V I V D S E E E R E D V A L Q M V G F S N P P  125
V L I K H G K G G K R T V R R L N E D D P V A R G  150
M R T Q E E K E E P S E A E S E S T V I N P L S L  175
P I V S A W E K G M E A A R A L M D K Y H V D N D  200
L K A N F K N L P D  Q V E A L  A V C K T W L N E  225
E H R G L Q L T F T S K K T F V T M M G R F L Q A  250
Y L Q S F A E V T Y K H H E P T G C A L W L H R C  275
A E I E G E L K C L H G S I M I N K E H V I E M D  300
V T S E N G Q R A L K E Q S S K A K I V K N R W G  325
R N V V Q I S N T D A R C C V P I D A A C P A N Q F  350
S G K S C G M F F S E G A K A Q V A F K Q I K A F  375
M Q A L Y P N A Q T G P I G H L L M P L R C E C N S  400
K P G H A P F L G R Q L P K L T P F A L S N A E D  425
L D A D L I S D K S V L A S V H H P A L I V F Q C  450
C N P V Y R N S R A Q G G G P N C D F K I S A P D  475
L L N A L V M V S L W S E N F T E L P R M V V P E  500
F K W S T K H Q Y R N V S L P V A H S D A R Q N P  525
F D F
Fig.11-2. Amino acid sequence of fld2 DBP (from Russell et al, 
1989).
is 5 -5  -GCG CGG ATC CCG GGfl AGfl GGfl GCfl GCG CGfl flflC C-3' and 
domnstream primer is 5 -GCG CGfl ATT CTT flTfl CGG CCG CCfl GAG
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CTT CCfl CTT GG-3‘; For C-terminal protein, upstream primer is 
5 -GCG CGG flTC CflG CCT GCC GflT CGT GTC TGC GTG G-3' and 
domnstream primer is 5 -GCG CGfl flTT CCC CCC CflC CCTTGC CGT 
CTG CGC CGT T-3'. EcoRI (GflflHC) and BamHi (GGflTCC) sites mere 
underlined.
Reaction mixes PCR mixes contained 50mM KCi, 10mM Tris- 
HCI (pH 8.4), 1.5mM MgClz, 200|iM each of the four dNTPs, 
100ng of Rd2 DNfl, IjxM of each primer and 2 units of Taq DNfl 
polymerase (Gibco) in a total uolume of 100]il.
Thermal cycle param eters These mere 94°C, 1.5 min for  
dénaturation; 500C, 2 min fo r annealing; 72oc, 3 min for  
elongation and a total of 30 cycles, fl condition of 94oc, 10 
mln mas incorporated at the beginning of the cycle for initial 
dénaturation of the tem plate and 72oc, 5 min mas used In 
final extension.
3. Inserting  DBP gene into pGEK-2T uector
The piamid DNfl of pGEH-2T and DBP DNfl fragments of 
PCR products mere double cleaned mith restriction enzymes 
EcoRI and BamHi, isolated by agarose gel electrophoresis, 
recouered from the gel and Joined together using T4 DNfl 
iigase.
Restriction endonuclease digestion Each digestion mas 
carried  out in the conditions recom m ended by the  
m anufacture fo r Indiuidual enzymes. The reaction mix 
contained 2 - 1 0^g of DNfl, 1-5|il (8 -10  units/|ii) of enzymes 
(Gibco) and 1 /10  uolumes of 10x b u ffe r supplied by the 
manufacture in a total uolume of 10-50|ii and mas incubated 
at 37°C for 1 hour-
107
Agarose gel electrophoresis (Maniatis et al, 1982) All DNfl 
samples mere run on mini gels containing 0.8-1%  (m /u)  
agarose in 1h TflE buffer (0.04M Tris-flcetate/0.002M EDTfl, pH 
8.0) at 40mfl of constant current for 3-4 hours, and uisualised 
under long maue UU light. Prior to loading the sample, a 1/10  
uolume of dye mix containing 0.25% bromophenol blue, 0.25% 
xylene cyanol and 25% Ficoll (type 400) in m ater mas added, 
and 5 -10  mln before uisualising the DNfl bands, ethidium  
bromide (10m g/m l in m ater) mas added to running buffer  
(IxTflE) to a final concentration of 1|ig/ml.
Recouery of DNfl from agarose gel The DNfl band of interest 
mas cut out from agarose gel under UU light and mashed up in 
an Eppendorf tube. Phenol/chloroform mas added jus t to 
couer the agarose and the mixture mas mixed mell using a 
f la t  toothpick and le ft  at -70°C  for more than 15 min. 
Immediately taken from -70°C, the mixture mas spun at high 
speed (12,0O0g) in bench microcentrifuge for 5 min. The 
phenol/chloroform phase mas remoued carefully from the 
bottom. Spun briefly, the supernatant mas transferred to a 
fresh tube and extracted by ether 2-3 times to remoue the 
trace of phenol as folloms: equal uolume of ether mas added 
and mixed by uortex and the top phase (ether) mas remoued 
and discarded. The DNfl mas recouered by ethanol 
precipitation as described before.
Ligation DNfl fragments of pGEH-2T (uector) and DBP (insert) 
mere ligated in a mixture of 10|il containing 0.5^1 of T4 DNfl 
Iigase (Gibco) and 2jLil of 5x Iigase buffer (Gibco). The reaction 
mas carried out at 12°C ouernight (12-16 hours). The molar 
ratio of uector DNfl to insert DNfl is about 1:3.
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4. In troducing recom binant plasmid into E. coli 
Preparation of competent cells An ouernight culture of E. coli 
cells (strain JM101) mas diluted at 1:100 into 100ml Luria- 
Broth in 500ml flask and Incubated at 37°C mith uigorous 
shaking until the cells reach an ODbbo of 0 .3 -0 ,4 . The cells 
mere pelleted by centrifugation at 1000g for 10 min at 4 ° [  
and resuspended in 10ml (1 /10 original uolume) of ice cold 1 x 
TSS (Chung et al, 1989). The TSS mas Luria-Broth containing 
10% (m /u) PEG-400 (polyethylene glycol LUt.400, DBH), 5% 
(u /u) DMSO (dimethyl sulfoxide. Sigma), and 50mM MgClz at a 
final pH of 6.5. Competent cells mere used immediately or left 
on ice for up to 24 hours or stored in TSS at -70oC. Frozen 
cells mere thamed on ice and used immediately. 
Transformation 0.1|ig-0.5|ig of plasmid DNfl or 5|il of ligation 
mix mas added into 0.1 ml competent cells. The mixture mas 
incubated on ice for 30 min mith occasional gentle mixing and 
heat shocked at 42°C for 90 sec. flfter this, the mixture mas 
transferred into a 10ml uniuersal containing 0.9ml of Luria- 
Broth mith 20mM glucose and incubated in a 37oc shaker for 1 
hour. 0.1-0.2ml of the aboue mixture mas then plated onto a 
Luria-flgar plate containing 100}ig/ml ampiciiiin and gromn at 
37°C for 18-20 hours.
5. Screening of tra n s fo rm a n ts
Recombinant clones mere selected and gromn in Luria- 
flgar containing 100|ig/|il ampiciiiin in a plate at 37°C. Their 
DNfl mas Isolated by rapid boiling method (Holmes and Qnigley, 
1981) and analysed by restriction endonuclease digestion.
109
STET boiling method of mini prep. One toothpick scrape of 
recombinant colony culture mas transferred to an Eppendorf 
tube. 200|il of STET buffer (8% sucrose/5% Triton 8 -100 /50m M  
EDTfl/50mM Tris-HCI, PH 8.0) and Î 6|il of lysozyme (10mg/mi 
fresh made in m ater) mere added. The mixture mas mell 
mixed using a toothpick and left at room tem perature for 5 
min. After mhich, the tube mas placed in a boiling m ater bath 
fo r 1 min and immediately spun at 12,000g for 5 min (MSE 
bench microcentrifuge). The pellet mas remoued using a 
toothpick and 150|il of Isopropanol mas added. The mixture 
mas mixed by uortex and le ft  at room tem perature  for  
fu r th e r  10 min. Plasmid DNfl mas then prec ip ita ted  by 
centrifugation at 12,000g fo r 5 min, mashed, dried, and 
resuspended in 40|liI of mater. 5|li! of the solution mas used in 
each digestion.
6. P urification  of the fusion protein
100ml of ouernight cultures of E. coli transformed mith 
parental or recombinant pGEH-2T plasmids mas added to 
900ml (1:10 dilution) of fresh medium and gromn at 37°C mith 
shaking until cells reach an ODeoe of 0.6. Then 1ml of 0.1M  
IPTG (Isopropyl-p-D-thiogalactopyranoside, Sigma) mas added 
to a final concentration of 0.1 mM and the cultures mere 
Incubated at 25°C mith shaking for a further 3 hours. The cells 
mere pelleted and lysed by sonicating (MSE ultrasonic probe) 
on ice in 10ml (1 /1 0  uolume) of PBS containing 0.5M NaCI, 
Im M  PMSF and 1% Triton H I00. The lysate mas sonicated 8-16  
times at 30 sec /tim e and clarified by centrifugation at 
31,400g for 30 min at 4°C (Beckman, Jfl20). The supernatant
n o
mas saued and mixed mith glutathlone-agarose beads (Sigma) 
fo r 2 hours at 4°C by continuous rotation. The glutathione  
agarose beads mere preutously smollen In PBS and mashed 
mith PBS alone first, PBS mith 1% Triton H I00 aftermards. The 
m ixture mas loaded onto a column and the column mas 
mashed mith PBS. The fusion protein mas then eluted from  
column by 15mM reduced g lu ta th io n e  (S ig m a )/0 .5 M  
NaCI/50mM Tris-HCI, pH 8.0 in 1ml fractions.
Results:
1. Construction o f a plasmid containing DBP genes
DBP genes of mhole length, N-terminal and C-terminal 
mere selected, amplified and inserted Into pGEH-2T uector as 
described in methods section. The recombinant plamids mere 
introduced into E. coli (Strain JM101) and the transformants  
mere screened for insertion of DBP genes. Using mini prep STET 
method, the recombinant DNR mas isolated. Double digestion 
PGEH-2T mith EcoRI and BamHi generated one big fragment 
about 5.6K In agarose gel (Fig.11-3. R. Lane 6). IDhile using 
BamHi and PstI, double digests of pGEH-2T generated one big 
fragm ent (5.6K) and one small fragm ent about 1.0 K in 
agarose gel (Fig.11-3. B. Lane 12 and C. Lane 6). Calculated 
from gene sequence, the molecular meight of three DBP 
inserts mhole length, N -term inal and C-terminal are 1.6K,
0.656K and 1.09K respectiuely. I f  a recombinant plasmid 
contains an Insert of mhole length DBP gene, double digesting 
the plasmid mith EcoRI and BamHi mould generate a fragment 
of 1.6K. Fig.11-3. R. Lanes 1-5 shomed double digests of
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F ig . l l -3 .  Construction of a plasmid containing DBP gene. R. 
EcoRI/BamHI double digests of recombinant DNR of pGEK-2T 
inserted mith mhole length DBP gene (lanes 1-5) and pGER-2T 
(lane 6). Molecular meight markers : 21.2K, 7.4K, 5.8K, 5.6K, 
4.8K and 2.18K, 1.77K, 1.23K, 1.03K and 0.65K. B. BamHI/PstI 
double digests of recombinant DNR of pGEK-2T inserted mith 
N-terminal DBP gene (lanes 1-11) and PGEK-2T (lane 12). C. 
BamHI/PstI double digests of recombinant DNR of pGEK-2T 
inserted mith C-terminal DBP gene (lanes 1-5) and PGEK-2T 
(lane 6). 0. PCR products of mhole length DBP gene (lane 9 and 
10) used tem plate from recombinant plasmid DNR of lane 4 
(F ig .l l -3 .  R) and N -term inal DBP gene (lanes 1-8 ) used 
template from recombinant plasmid DNR of lanes 6, 8, 10 and 
11 (F ig .ll-3. B).
recombinant plasmids mith EcoRI and BamHi. R band appeared 
in lane 4 mas jus t belom the meight m arker of 1.77K, 
suggesting that the mhole length DBP gene (1.6K) mas
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inserted in this plasmid. This Luas confirmed by a PCR reaction 
using the recombinant plasmid DNH containing an insert of 
uihole length DBP gene (shoum In lane 4) as a template (F ig .il-  
3. D. Lane 9 and 10). Double digests of a recombinant plasmid 
Luith BamHi and PstI mould generate a small fragm ent of 
1.65K (1.0K+Q.65K) fo r N -te rm in a l insert and a 2.09K  
(1.0K+1.09K) fragment for C-terminal Insert. F ig.ii-3. B. Lanes 
6 ,8 ,  10 and 11 shouied a band uiith an expected size of about 
1.65K, suggesting an insert of N-terminal DBP gene (0.65K) in 
these plasmids. This mas also confirmed by a PCR reaction  
using these plasmids ONR as templates (Fig.11-3. D. Lanes 1-8). 
Fig .ii-3 . C. Lanes 1-5 shomed a band about 1.03K, suggesting 
that there mere no inserts in these plasmids since an 
expected small fragment generated from double digests mith 
BamHI and PstI mould be 1.65K for a recombinant plasmid 
containing N-term inal insert and 2.09K fo r a recombinant 
plasmid containing C-terminal Insert.
2. Production of expressed DBP in £. coil
Rn ouernight culture of bacterial ceils transformed mith 
PGER-2T alone or pGER-2T inserted mith mhole length DBP gene 
or N-terminai of DBP gene mas diluted 1:10 in fresh medium, 
gromn at 37°C to 00688=0.6 and IPTG added to 0.1 mM. Samples 
mere taken a fte r  3 hours induction and separated by 16% SDS 
PAGE foliomed by staining mith coomassie blue. GST mas 
clearly present in gel a f te r  Induction (Fig.11-4. A. Lane 1) but 
fusion proteins mere not (F ig .i i-4 . A. Lanes 3 and 5). By 
reducing the tem perature of induction, a fusion protein mas 
demonstrated in a mestern blot (Fig.ll-4. B. Lane 5). Using
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F ig . l l - 4 .  Production of expressed DBP in E. coli (mestern  
blotting): fl. Expression and induction of fusion proteins. Lane 
1: PGEH-2T uiith iPTG; Lane 2: pGEH-2T uiithout IPTG; Lane 3: 
recombinant pGEH 2T/N terminai insert mith iPTG; Lane 4: 
recombinant pGEH 2T/N-terminai insert mithout iPTG; Lane 5: 
recombinant pGEH-2T/mhole iength insert mith iPTG; Lane 6: 
recombinant pGEB-2T/mhoie iength insert mithout IPTG; Lane 
7: purified DBP. B. The effect of tem perature on induction. 
Lanes 1 & 2: pGEH-2T induced at 250[ & 370[; Lanes 3 & 4: 
PGEH-2T mock-induced at 250[ & 37°C; Lanes 5 & 6: pGEH- 
2T/UJhole length insert induced at 25°C & 370C; Lanes 7 & 8: 
pGEB-2T/lUhole length insert mock-induced at 250[ D 37°C.
d iffe ren t concentration (0 .1 - lm M ) of IPTG and d iffe ren t  
induction time (1 -6  hours), these results haue not been 
improued (data not shomn).
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Discussion:
in order to ascerta in  the re lationship  hetm een  
phosphorylation status and uarious functions of DBP, it mould 
be uery useful to haue the protein expressed totally deuoid of 
phosphorylation, since bacterial protein kinases apparently do 
not catalyze the phosphorylation of exogenous proteins 
(Rickenberg and Leichtiing, 1986 ) and protein kinases in 
prokaryotes are not as preualent as in eukaryotes. Thus 
expressing DBP in bacteria could be a possible may to get an 
unphosphorylated DBP. There is an exam ple (Barik and 
Banerjee, 1991) that a phosphoprotein synthesized In E. coli 
also lacks phosphorylation but can be phosphorylated in uitro 
and is also functionally actiue in uitro. Rpart from this, 
bacterial expression mould prouide a quick and inexpensiue 
system in mhich mutagenesis can by carried out uia PCR (Ho et 
ai, 1989). Ail these considerations mould be facilitated by the 
expression of DBP in E. coll. Unfortunately, although the DBP 
gene mas inserted into pGER-2T uector (Fig.11-3) and the 
recombinant plasmid mas Introduced into E. coli, the  
production of fusion protein mas uery lom. The reason for that 
is currently unclear. Eukaryotic proteins expressed in E. coli 
are not properly modified (Schein, 1989), and bacterial 
cytoplasm is less stable in pH and higher in salt than 
eukaryotes. These probably mould affect the expression of 
certain eukaryotic proteins. Because proteins expressed in 
bacterial are not properly folded this probably makes them 
less resistant to bacterial proteases.
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Conclusions:
1. Tujo antibodies an ti-P ty r  (phosphotyrosine) polyclonal 
antibody (PHb) and anti-DBP (Rd2 DNR-binding protein)  
monoclonal (MRb) mere made and used in a study of DBP 
phosphorylation.
Rnti-P tyr Pflb recognized ph os phot y ro sine-containing  
protein EGFR in fixed cells and crude cell ex tracts  by 
im m unofluorescence, Im m unoprécip itation and m estern  
blotting but failed to detect Ptyr in DBP in these assays. This 
could possibly be due the lim itation of the assay system  
(including the anti-P tyr itself) and the uery lom leuel of Ptyr 
in the protein.
Rnti-DBP MRb possibly recognized one m a jo r linear  
antigenic site of DBP. Binding to this MRb apparently did not 
affe c t the binding of DBP to DNR mhiie binding of DNH 
apparently affected the binding of DBP to this MRb and the 
stability of the complex of DBP-MRb. Probably binding of DNR 
to DBP induces a significant change in conformation resulting 
in the unauailability of the epitope.
2. DBP mas not phosphorylated in an in uitro phosphorylation 
system under the conditions stated aboue, but a peptide  
containing the putatiue tyrosine phosphorylation site of DBP 
and Its surrounding amino acids mas shomn to be 
phosphorylated in uitro. This implicated a potential of DBP to 
be phosphorylated at tyrosine and a possibility that DBP could 
be tyrosyi-phosphorylated in uiuo under certain conditions.
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Probably in an in uitro situation, the conformation of DBP mas 
such that the phosphorylation of tyrosine mas not accessible.
lodination of DBP abolished DNR-blnding actiuity of DBP 
but did not a lter its antigenicity and apparent molecule size, 
suggesting an inuoluement of tyrosine residues in DNR binding 
of DBP and a possibility that tyrosine-phosphorylation of DBP 
might indirectly regulate its DNR-binding actiuity by altering 
Its local conformation ( or enuironment).
Using synthetic peptide substrates, no tyrosine kinase 
actiuity mas detected in Rd2 infected Hela cells, Homeuer 
mhen Hela cells mere infected in the presence of Genistein, a 
highly specific inhibitor of tyrosine kinases, the synthesis of 
hexon (a late protein) mas reduced, suggesting that tyrosine 
kinase might be required for Rd2 uiral DNR synthesis.
3. Rn attem pt to express DBP In E.coli mas also made in 
order to carry out oligonucleotide-directed mutageniseis. The 
DBP gene mas inserted into pGEH-2T uector and transformed  
into E.coli, but the production of DBP in E.coli mas uerg lom.
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